activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177476	CHEMBL764602	Inhibition of PAK2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	78.0	CHEMBL4487	Homo sapiens	Activity	%	78.0
	177476	CHEMBL764602	Inhibition of PAK2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	78.0	CHEMBL4487	Homo sapiens	Activity	%	78.0
	178789	CHEMBL764602	Inhibition of PAK2	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	94.0	CHEMBL4487	Homo sapiens	Activity	%	94.0
	182536	CHEMBL764602	Inhibition of PAK2	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	93.0	CHEMBL4487	Homo sapiens	Activity	%	93.0
	1734154	CHEMBL854401	Residual activity at human PAK2 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	178.0	CHEMBL4487	Homo sapiens	Activity	%	178.0
	1765471	CHEMBL871543	Inhibition of Pak2 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	>	IC50	nM	25000.0	CHEMBL4487	Homo sapiens	IC50	uM	25.0
	1765500	CHEMBL871543	Inhibition of Pak2 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	>	IC50	nM	25000.0	CHEMBL4487	Homo sapiens	IC50	uM	25.0
	1769412	CHEMBL910929	Inhibition of PAK2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4487	Homo sapiens	IC50	uM	1.0
	1790068	CHEMBL855329	Percentage activity of human PAK2 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	88.0	CHEMBL4487	Homo sapiens	Activity	%	88.0
	2025154	CHEMBL886996	Inhibition of human PAK2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	103.0	CHEMBL4487	Homo sapiens	Inhibition	%	103.0
	2025399	CHEMBL886996	Inhibition of human PAK2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	93.0	CHEMBL4487	Homo sapiens	Inhibition	%	93.0
	2025400	CHEMBL886996	Inhibition of human PAK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	102.0	CHEMBL4487	Homo sapiens	Inhibition	%	102.0
	2025401	CHEMBL886996	Inhibition of human PAK2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	100.0	CHEMBL4487	Homo sapiens	Inhibition	%	100.0
	2120480	CHEMBL951128	Inhibition of PAK2 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	>	IC50	nM	25000.0	CHEMBL4487	Homo sapiens	IC50	uM	25.0
	2147332	CHEMBL922017	Activity of human PAK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	2248267	CHEMBL1012708	Inhibition of PAK2 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	2248268	CHEMBL1012708	Inhibition of PAK2 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	INH	%	-1.0
	2356982	CHEMBL958278	Inhibition of PAK2 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	2470304	CHEMBL987224	Inhibition of PAK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
Not Evaluated	2476577	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2476780	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4487	Homo sapiens	Activity		
	2477878	CHEMBL988911	Binding affinity to human PAK2	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Kd	nM	14000.0	CHEMBL4487	Homo sapiens	Kd	nM	14000.0
Not Evaluated	2478619	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2478822	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2479677	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4487	Homo sapiens	Activity		
	2511598	CHEMBL1021076	Inhibition of PAK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL4487	Homo sapiens	IC50	uM	0.001
	2567267	CHEMBL975454	Inhibition of human PAK2 assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	103.0	CHEMBL4487	Homo sapiens	Activity	%	103.0
Not Evaluated	2577298	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2577501	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2593503	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4487	Homo sapiens	Activity		
	2593706	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	6.6	CHEMBL4487	Homo sapiens	Activity	%	6.6
Not Evaluated	2593972	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2594915	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2595118	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2595184	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2596315	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2597584	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4487	Homo sapiens	Activity		
Not Evaluated	2597787	CHEMBL992639	Binding affinity to human PAK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4487	Homo sapiens	Activity		
	2721672	CHEMBL1054304	Inhibition of PAK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	2903006	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903007	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903008	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903009	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903010	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903011	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903012	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903013	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903014	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903015	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903016	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903017	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903018	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903019	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903020	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903021	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903022	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903023	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903024	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903025	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903026	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903027	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903028	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903029	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903030	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903031	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	3300.0	CHEMBL4487	Homo sapiens	Kd	nM	3300.0
	2903032	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903033	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903034	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903035	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903036	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903037	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903038	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.1	CHEMBL4487	Homo sapiens	Kd	nM	3.1
	2903039	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903040	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903041	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5700.0	CHEMBL4487	Homo sapiens	Kd	nM	5700.0
	2903042	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2903043	CHEMBL1050828	Binding constant for PAK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	2921233	CHEMBL1048305	Inhibition of PAK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	85.0	CHEMBL4487	Homo sapiens	Activity	%	85.0
	2938469	CHEMBL1041396	Inhibition of PAK2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
Not Active	2938609	CHEMBL1040622	Inhibition of PAK2 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	2944865	CHEMBL1049988	Inhibition of PAK2 at 2 uM	B	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1		CHEMBL583194	=	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	2946941	CHEMBL1054413	Inhibition of PAK2 at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	2993572	CHEMBL1040947	Inhibition of human recombinant PAK2	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	nM	10000.0
	3052428	CHEMBL1069809	Residual activity of PAK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL4487	Homo sapiens	Residual activity	%	97.0
	3052680	CHEMBL1041167	Residual activity of PAK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	103.0	CHEMBL4487	Homo sapiens	Residual activity	%	103.0
	3053989	CHEMBL1050320	Residual activity of PAK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	48.0	CHEMBL4487	Homo sapiens	Residual activity	%	48.0
	3054241	CHEMBL1069809	Residual activity of PAK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	111.0	CHEMBL4487	Homo sapiens	Residual activity	%	111.0
	3055528	CHEMBL1041167	Residual activity of PAK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	124.0	CHEMBL4487	Homo sapiens	Residual activity	%	124.0
	3056833	CHEMBL1050320	Residual activity of PAK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	54.0	CHEMBL4487	Homo sapiens	Residual activity	%	54.0
	3057085	CHEMBL1069809	Residual activity of PAK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL4487	Homo sapiens	Residual activity	%	93.0
	3058405	CHEMBL1041167	Residual activity of PAK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL4487	Homo sapiens	Residual activity	%	102.0
	3059689	CHEMBL1050320	Residual activity of PAK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	49.0	CHEMBL4487	Homo sapiens	Residual activity	%	49.0
	3062493	CHEMBL1037980	Binding affinity to human PAK2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	36.0	CHEMBL4487	Homo sapiens	Activity	%	36.0
	3063628	CHEMBL1074894	Binding affinity to human PAK2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	14.0	CHEMBL4487	Homo sapiens	Activity	%	14.0
	3063718	CHEMBL1042480	Binding affinity to human PAK2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	72.0	CHEMBL4487	Homo sapiens	Activity	%	72.0
	3066873	CHEMBL1066079	Inhibition of PAK2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	3066963	CHEMBL1066079	Inhibition of PAK2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	3213996	CHEMBL1116744	Inhibition of PAK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	3224905	CHEMBL1100983	Inhibition of PAK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3226284	CHEMBL1100983	Inhibition of PAK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3260061	CHEMBL1104330	Inhibition of PAK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	79.0	CHEMBL4487	Homo sapiens	Activity	%	79.0
	3261412	CHEMBL1104330	Inhibition of PAK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	75.0	CHEMBL4487	Homo sapiens	Activity	%	75.0
Not Active	3272440	CHEMBL1108312	Inhibition of PAK2	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272441	CHEMBL1108312	Inhibition of PAK2	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272442	CHEMBL1108312	Inhibition of PAK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272443	CHEMBL1108312	Inhibition of PAK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272444	CHEMBL1108312	Inhibition of PAK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272445	CHEMBL1108312	Inhibition of PAK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272446	CHEMBL1108312	Inhibition of PAK2	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272447	CHEMBL1108312	Inhibition of PAK2	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272448	CHEMBL1108312	Inhibition of PAK2	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	3272449	CHEMBL1108312	Inhibition of PAK2	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	3272450	CHEMBL1108312	Inhibition of PAK2	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL4487	Homo sapiens	INH	%	20.0
Not Active	3272451	CHEMBL1108312	Inhibition of PAK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	3316798	CHEMBL1120357	Inhibition of PAK2 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	2.0	CHEMBL4487	Homo sapiens	INH	%	2.0
	3326160	CHEMBL1168769	Inhibition of PAK2 at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3332066	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3333481	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3334886	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3336306	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3337602	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3338933	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3339187	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3340490	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3341848	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3343295	CHEMBL1166604	Inhibition of PAK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	3358714	CHEMBL1174956	Inhibition of PAK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	84.0	CHEMBL4487	Homo sapiens	INH	%	84.0
	3359156	CHEMBL1174956	Inhibition of PAK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	76.0	CHEMBL4487	Homo sapiens	INH	%	76.0
	3400031	CHEMBL1217228	Inhibition of human PAK2 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	45.0	CHEMBL4487	Homo sapiens	INH	%	45.0
	3443470	CHEMBL1244236	Inhibition of PAK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	8.0	CHEMBL4487	Homo sapiens	INH	%	8.0
	3443687	CHEMBL1244236	Inhibition of PAK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	3444842	CHEMBL1244236	Inhibition of PAK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	3445229	CHEMBL1244550	Binding affinity to PAK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	43.0	CHEMBL4487	Homo sapiens	Kd	nM	43.0
	3445466	CHEMBL1244236	Inhibition of PAK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL4487	Homo sapiens	INH	%	4.0
	3445683	CHEMBL1244236	Inhibition of PAK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	INH	%	-1.0
	3448036	CHEMBL1249689	Inhibition of human PAK2 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	9.0	CHEMBL4487	Homo sapiens	INH	%	9.0
	3448112	CHEMBL1249689	Inhibition of human PAK2 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	3448542	CHEMBL1244550	Binding affinity to PAK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	3448999	CHEMBL1244550	Binding affinity to PAK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2100.0	CHEMBL4487	Homo sapiens	Kd	nM	2100.0
	3449772	CHEMBL1244550	Binding affinity to PAK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	3450170	CHEMBL1244550	Binding affinity to PAK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	3450379	CHEMBL1244550	Binding affinity to PAK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	3451090	CHEMBL1244550	Binding affinity to PAK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	uM	10.0
	3463304	CHEMBL1252606	Inhibition of PAK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	55.0	CHEMBL4487	Homo sapiens	INH	%	55.0
	3463848	CHEMBL1252606	Inhibition of PAK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	9.0	CHEMBL4487	Homo sapiens	INH	%	9.0
	3464067	CHEMBL1252606	Inhibition of PAK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	3601438	CHEMBL1292412	Inhibition of PAK2	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	>	IC50	nM	30000.0	CHEMBL4487	Homo sapiens	IC50	uM	30.0
	5120406	CHEMBL1648657	Inhibition of human PAK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL4487	Homo sapiens	INH	%	108.0
	5133702	CHEMBL1648710	Inhibition of PAK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	81.0	CHEMBL4487	Homo sapiens	Activity	%	81.0
	5133797	CHEMBL1648710	Inhibition of PAK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	80.0	CHEMBL4487	Homo sapiens	Activity	%	80.0
	5133874	CHEMBL1648710	Inhibition of PAK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	90.0	CHEMBL4487	Homo sapiens	Activity	%	90.0
	5243744	CHEMBL1685848	Inhibition of PAK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	93.0	CHEMBL4487	Homo sapiens	INH	%	93.0
	5243852	CHEMBL1686064	Inhibition of PAK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	72.0	CHEMBL4487	Homo sapiens	INH	%	72.0
	5243965	CHEMBL1685848	Inhibition of PAK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	83.0	CHEMBL4487	Homo sapiens	INH	%	83.0
	5244073	CHEMBL1686064	Inhibition of PAK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	38.0	CHEMBL4487	Homo sapiens	INH	%	38.0
	5244946	CHEMBL1685848	Inhibition of PAK2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	100.0	CHEMBL4487	Homo sapiens	INH	%	100.0
	5245054	CHEMBL1686064	Inhibition of PAK2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	89.0	CHEMBL4487	Homo sapiens	INH	%	89.0
	5245205	CHEMBL1685848	Inhibition of PAK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	114.0	CHEMBL4487	Homo sapiens	INH	%	114.0
	5246035	CHEMBL1686064	Inhibition of PAK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	103.0	CHEMBL4487	Homo sapiens	INH	%	103.0
	6325321	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	36.0	CHEMBL4487	Homo sapiens	INH	%	36.0
	6325351	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	6325382	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	4.0	CHEMBL4487	Homo sapiens	INH	%	4.0
	6325415	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	6325446	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	17.0	CHEMBL4487	Homo sapiens	INH	%	17.0
	6325476	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	16.0	CHEMBL4487	Homo sapiens	INH	%	16.0
	6325504	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	7.0	CHEMBL4487	Homo sapiens	INH	%	7.0
	6325534	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	6325877	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	32.0	CHEMBL4487	Homo sapiens	INH	%	32.0
	6325907	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	6325936	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	6325965	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	6325994	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	6326023	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	6326052	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	6326081	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	2.0	CHEMBL4487	Homo sapiens	INH	%	2.0
	6326111	CHEMBL1820087	Inhibition of PAK2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	4.0	CHEMBL4487	Homo sapiens	INH	%	4.0
	6341103	CHEMBL1826675	Activity of PAK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	6352254	CHEMBL1825902	Inhibition of PAK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	91.0	CHEMBL4487	Homo sapiens	Activity	%	91.0
	6375430	CHEMBL1840250	Inhibition of PAK2 at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	51.0	CHEMBL4487	Homo sapiens	INH	%	51.0
	6386358	CHEMBL1839857	Inhibition of recombinant PAK2	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	7567267	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7567726	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7568197	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7568655	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7569240	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7569700	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7570193	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7570620	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7571216	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7571673	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7571707	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7572170	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7572586	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	5800.0	CHEMBL4487	Homo sapiens	Kd	nM	5800.0
	7573197	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	3300.0	CHEMBL4487	Homo sapiens	Kd	nM	3300.0
	7573688	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7574157	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	3300.0	CHEMBL4487	Homo sapiens	Kd	nM	3300.0
	7574565	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7575194	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7575665	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7576130	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7576538	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	6000.0	CHEMBL4487	Homo sapiens	Kd	nM	6000.0
	7576707	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7577166	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7577644	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2700.0	CHEMBL4487	Homo sapiens	Kd	nM	2700.0
	7578114	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	3200.0	CHEMBL4487	Homo sapiens	Kd	nM	3200.0
	7578519	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7578715	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1500.0	CHEMBL4487	Homo sapiens	Kd	nM	1500.0
	7579089	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7579539	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7580013	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7580482	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7580885	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5700.0	CHEMBL4487	Homo sapiens	Kd	nM	5700.0
	7581073	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7581458	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7581903	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7582374	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7583419	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7583816	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7584261	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7584732	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7584752	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	340.0	CHEMBL4487	Homo sapiens	Kd	nM	340.0
	7585156	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7585749	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7586157	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7586603	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7587086	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7587710	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7588129	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	43.0	CHEMBL4487	Homo sapiens	Kd	nM	43.0
	7588611	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7589062	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7589675	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7590124	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7590598	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7591049	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7591628	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7592100	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7592573	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7593026	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1900.0	CHEMBL4487	Homo sapiens	Kd	nM	1900.0
	7593173	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7593608	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7594080	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	270.0	CHEMBL4487	Homo sapiens	Kd	nM	270.0
	7594553	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7595005	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7595141	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7595585	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7596059	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7596530	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7596977	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.1	CHEMBL4487	Homo sapiens	Kd	nM	3.1
	7597113	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7597566	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7598039	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	79.0	CHEMBL4487	Homo sapiens	Kd	nM	79.0
	7598509	CHEMBL1908569	Binding constant for PAK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4487	Homo sapiens	Kd	nM	10000.0
	7922728	CHEMBL1919223	Inhibition of human recombinant PAK2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	-6.0	CHEMBL4487	Homo sapiens	INH	%	-6.0
	7961085	CHEMBL1931524	Inhibition of PAK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4487	Homo sapiens	IC50	uM	30.0
	7961086	CHEMBL1931524	Inhibition of PAK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4487	Homo sapiens	IC50	uM	30.0
	7969771	CHEMBL1929872	Inhibition of PAK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	79.0	CHEMBL4487	Homo sapiens	Activity	%	79.0
	7971370	CHEMBL1929913	Inhibition of PAK2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
	8004336	CHEMBL1943326	Inhibition of human PAK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL4487	Homo sapiens	INH	%	35.0
	8004337	CHEMBL1943326	Inhibition of human PAK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL4487	Homo sapiens	INH	%	35.0
	8004338	CHEMBL1943326	Inhibition of human PAK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL4487	Homo sapiens	INH	%	35.0
	8004339	CHEMBL1943326	Inhibition of human PAK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL4487	Homo sapiens	INH	%	35.0
	8013117	CHEMBL1948136	Inhibition of PAK2 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	8061343	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.23	CHEMBL4487	Homo sapiens	Inhibition	%	-1.23
	8061520	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.63	CHEMBL4487	Homo sapiens	Inhibition	%	-0.63
	8061851	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.38	CHEMBL4487	Homo sapiens	Inhibition	%	-0.38
	8062042	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.8	CHEMBL4487	Homo sapiens	Inhibition	%	0.8
	8062382	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.04	CHEMBL4487	Homo sapiens	Inhibition	%	1.04
	8062544	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.42	CHEMBL4487	Homo sapiens	Inhibition	%	1.42
	8062866	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.82	CHEMBL4487	Homo sapiens	Inhibition	%	1.82
	8063222	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.01	CHEMBL4487	Homo sapiens	Inhibition	%	-1.01
	8063389	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.08	CHEMBL4487	Homo sapiens	Inhibition	%	-0.08
	8063721	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.67	CHEMBL4487	Homo sapiens	Inhibition	%	0.67
	8063903	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.31	CHEMBL4487	Homo sapiens	Inhibition	%	0.31
	8064242	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.39	CHEMBL4487	Homo sapiens	Inhibition	%	0.39
	8064452	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.43	CHEMBL4487	Homo sapiens	Inhibition	%	0.43
	8064814	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.18	CHEMBL4487	Homo sapiens	Inhibition	%	0.18
	8064980	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.63	CHEMBL4487	Homo sapiens	Inhibition	%	0.63
	8065204	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-1.11	CHEMBL4487	Homo sapiens	Inhibition	%	-1.11
	8065320	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.08	CHEMBL4487	Homo sapiens	Inhibition	%	1.08
	8065495	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.01	CHEMBL4487	Homo sapiens	Inhibition	%	1.01
	8065719	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.43	CHEMBL4487	Homo sapiens	Inhibition	%	1.43
	8065834	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.04	CHEMBL4487	Homo sapiens	Inhibition	%	0.04
	8066044	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.42	CHEMBL4487	Homo sapiens	Inhibition	%	-0.42
	8066268	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.74	CHEMBL4487	Homo sapiens	Inhibition	%	0.74
	8066404	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.91	CHEMBL4487	Homo sapiens	Inhibition	%	0.91
	8066794	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.84	CHEMBL4487	Homo sapiens	Inhibition	%	-0.84
	8066918	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.73	CHEMBL4487	Homo sapiens	Inhibition	%	0.73
	8067317	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8067438	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.22	CHEMBL4487	Homo sapiens	Inhibition	%	0.22
	8067662	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.13	CHEMBL4487	Homo sapiens	Inhibition	%	-0.13
	8067872	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.13	CHEMBL4487	Homo sapiens	Inhibition	%	1.13
	8068007	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	-0.1	CHEMBL4487	Homo sapiens	Inhibition	%	-0.1
	8068231	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.59	CHEMBL4487	Homo sapiens	Inhibition	%	2.59
	8068395	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.33	CHEMBL4487	Homo sapiens	Inhibition	%	0.33
	8068520	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.39	CHEMBL4487	Homo sapiens	Inhibition	%	0.39
	8068744	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.64	CHEMBL4487	Homo sapiens	Inhibition	%	0.64
	8068918	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.9	CHEMBL4487	Homo sapiens	Inhibition	%	1.9
	8069267	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.1	CHEMBL4487	Homo sapiens	Inhibition	%	-0.1
	8069562	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.16	CHEMBL4487	Homo sapiens	Inhibition	%	5.16
	8069723	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.77	CHEMBL4487	Homo sapiens	Inhibition	%	-0.77
	8070073	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.15	CHEMBL4487	Homo sapiens	Inhibition	%	0.15
	8070245	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.33	CHEMBL4487	Homo sapiens	Inhibition	%	1.33
	8070594	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.93	CHEMBL4487	Homo sapiens	Inhibition	%	0.93
	8070892	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	37.84	CHEMBL4487	Homo sapiens	Inhibition	%	37.84
	8071049	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.05	CHEMBL4487	Homo sapiens	Inhibition	%	1.05
	8071399	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-2.02	CHEMBL4487	Homo sapiens	Inhibition	%	-2.02
	8071572	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.31	CHEMBL4487	Homo sapiens	Inhibition	%	1.31
	8071796	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.69	CHEMBL4487	Homo sapiens	Inhibition	%	2.69
	8071921	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.21	CHEMBL4487	Homo sapiens	Inhibition	%	-0.21
	8072235	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.19	CHEMBL4487	Homo sapiens	Inhibition	%	-1.19
	8072392	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.72	CHEMBL4487	Homo sapiens	Inhibition	%	0.72
	8072616	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.73	CHEMBL4487	Homo sapiens	Inhibition	%	1.73
	8072741	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.91	CHEMBL4487	Homo sapiens	Inhibition	%	-0.91
	8073132	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.61	CHEMBL4487	Homo sapiens	Inhibition	%	3.61
	8073257	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.5	CHEMBL4487	Homo sapiens	Inhibition	%	-1.5
	8073481	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.42	CHEMBL4487	Homo sapiens	Inhibition	%	-0.42
	8073600	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.16	CHEMBL4487	Homo sapiens	Inhibition	%	0.16
	8073833	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.23	CHEMBL4487	Homo sapiens	Inhibition	%	0.23
	8074209	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.63	CHEMBL4487	Homo sapiens	Inhibition	%	0.63
	8074339	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.09	CHEMBL4487	Homo sapiens	Inhibition	%	-1.09
	8074563	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.86	CHEMBL4487	Homo sapiens	Inhibition	%	-0.86
	8074720	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.39	CHEMBL4487	Homo sapiens	Inhibition	%	1.39
	8075071	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.87	CHEMBL4487	Homo sapiens	Inhibition	%	0.87
	8075182	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.31	CHEMBL4487	Homo sapiens	Inhibition	%	-0.31
	8075419	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.93	CHEMBL4487	Homo sapiens	Inhibition	%	-2.93
	8075643	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.92	CHEMBL4487	Homo sapiens	Inhibition	%	-0.92
	8075784	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.04	CHEMBL4487	Homo sapiens	Inhibition	%	2.04
	8076150	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.58	CHEMBL4487	Homo sapiens	Inhibition	%	-1.58
	8076298	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8076656	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.27	CHEMBL4487	Homo sapiens	Inhibition	%	-0.27
	8076758	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.59	CHEMBL4487	Homo sapiens	Inhibition	%	-0.59
	8076982	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.77	CHEMBL4487	Homo sapiens	Inhibition	%	-0.77
	8077229	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	7.41	CHEMBL4487	Homo sapiens	Inhibition	%	7.41
	8077357	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.87	CHEMBL4487	Homo sapiens	Inhibition	%	0.87
	8077732	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.3	CHEMBL4487	Homo sapiens	Inhibition	%	-0.3
	8077875	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.32	CHEMBL4487	Homo sapiens	Inhibition	%	0.32
	8078099	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.01	CHEMBL4487	Homo sapiens	Inhibition	%	-0.01
	8078238	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.12	CHEMBL4487	Homo sapiens	Inhibition	%	-1.12
	8078564	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.65	CHEMBL4487	Homo sapiens	Inhibition	%	-0.65
	8078814	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	48.93	CHEMBL4487	Homo sapiens	Inhibition	%	48.93
	8078930	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.71	CHEMBL4487	Homo sapiens	Inhibition	%	0.71
	8079154	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.48	CHEMBL4487	Homo sapiens	Inhibition	%	0.48
	8079312	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.74	CHEMBL4487	Homo sapiens	Inhibition	%	-2.74
	8079678	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.28	CHEMBL4487	Homo sapiens	Inhibition	%	0.28
	8079817	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.29	CHEMBL4487	Homo sapiens	Inhibition	%	-1.29
	8080146	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.29	CHEMBL4487	Homo sapiens	Inhibition	%	-0.29
	8080398	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.84	CHEMBL4487	Homo sapiens	Inhibition	%	-2.84
	8080737	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.61	CHEMBL4487	Homo sapiens	Inhibition	%	-0.61
	8080901	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.42	CHEMBL4487	Homo sapiens	Inhibition	%	-0.42
	8081260	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.13	CHEMBL4487	Homo sapiens	Inhibition	%	-0.13
	8081404	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.19	CHEMBL4487	Homo sapiens	Inhibition	%	1.19
	8081628	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.08	CHEMBL4487	Homo sapiens	Inhibition	%	2.08
	8081731	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.61	CHEMBL4487	Homo sapiens	Inhibition	%	0.61
	8081983	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.1	CHEMBL4487	Homo sapiens	Inhibition	%	0.1
	8082320	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.47	CHEMBL4487	Homo sapiens	Inhibition	%	0.47
	8082493	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.09	CHEMBL4487	Homo sapiens	Inhibition	%	-3.09
	8082717	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.02	CHEMBL4487	Homo sapiens	Inhibition	%	-2.02
	8082840	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.22	CHEMBL4487	Homo sapiens	Inhibition	%	2.22
	8083220	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.82	CHEMBL4487	Homo sapiens	Inhibition	%	0.82
	8083319	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.45	CHEMBL4487	Homo sapiens	Inhibition	%	-0.45
	8083543	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.99	CHEMBL4487	Homo sapiens	Inhibition	%	0.99
	8083573	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.06	CHEMBL4487	Homo sapiens	Inhibition	%	-2.06
	8083797	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.54	CHEMBL4487	Homo sapiens	Inhibition	%	-1.54
	8083907	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.07	CHEMBL4487	Homo sapiens	Inhibition	%	0.07
	8084316	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.04	CHEMBL4487	Homo sapiens	Inhibition	%	1.04
	8084434	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.3	CHEMBL4487	Homo sapiens	Inhibition	%	2.3
	8084819	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.78	CHEMBL4487	Homo sapiens	Inhibition	%	2.78
	8085141	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.37	CHEMBL4487	Homo sapiens	Inhibition	%	0.37
	8085397	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.02	CHEMBL4487	Homo sapiens	Inhibition	%	-2.02
	8085505	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.19	CHEMBL4487	Homo sapiens	Inhibition	%	-0.19
	8085729	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.86	CHEMBL4487	Homo sapiens	Inhibition	%	0.86
	8085918	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.9	CHEMBL4487	Homo sapiens	Inhibition	%	3.9
	8086033	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.73	CHEMBL4487	Homo sapiens	Inhibition	%	0.73
	8086257	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.51	CHEMBL4487	Homo sapiens	Inhibition	%	0.51
	8086419	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	0.62	CHEMBL4487	Homo sapiens	Inhibition	%	0.62
	8086742	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.38	CHEMBL4487	Homo sapiens	Inhibition	%	-0.38
	8086953	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.59	CHEMBL4487	Homo sapiens	Inhibition	%	1.59
	8087335	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.42	CHEMBL4487	Homo sapiens	Inhibition	%	0.42
	8087449	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.86	CHEMBL4487	Homo sapiens	Inhibition	%	1.86
	8087673	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.73	CHEMBL4487	Homo sapiens	Inhibition	%	1.73
	8087811	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.83	CHEMBL4487	Homo sapiens	Inhibition	%	1.83
	8088177	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.45	CHEMBL4487	Homo sapiens	Inhibition	%	4.45
	8088325	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.21	CHEMBL4487	Homo sapiens	Inhibition	%	-0.21
	8088677	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.89	CHEMBL4487	Homo sapiens	Inhibition	%	1.89
	8088770	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.34	CHEMBL4487	Homo sapiens	Inhibition	%	3.34
	8088994	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.08	CHEMBL4487	Homo sapiens	Inhibition	%	2.08
	8089122	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.01	CHEMBL4487	Homo sapiens	Inhibition	%	-1.01
	8089494	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.39	CHEMBL4487	Homo sapiens	Inhibition	%	0.39
	8089614	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.65	CHEMBL4487	Homo sapiens	Inhibition	%	0.65
	8089838	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.78	CHEMBL4487	Homo sapiens	Inhibition	%	1.78
	8090018	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.84	CHEMBL4487	Homo sapiens	Inhibition	%	-1.84
	8090183	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.01	CHEMBL4487	Homo sapiens	Inhibition	%	1.01
	8090574	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.56	CHEMBL4487	Homo sapiens	Inhibition	%	0.56
	8090713	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.6	CHEMBL4487	Homo sapiens	Inhibition	%	-0.6
	8090937	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.53	CHEMBL4487	Homo sapiens	Inhibition	%	0.53
	8091142	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.34	CHEMBL4487	Homo sapiens	Inhibition	%	0.34
	8091279	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.88	CHEMBL4487	Homo sapiens	Inhibition	%	0.88
	8091503	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.2	CHEMBL4487	Homo sapiens	Inhibition	%	2.2
	8091658	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.8	CHEMBL4487	Homo sapiens	Inhibition	%	0.8
	8091998	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.5	CHEMBL4487	Homo sapiens	Inhibition	%	1.5
	8092135	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.54	CHEMBL4487	Homo sapiens	Inhibition	%	0.54
	8092510	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.13	CHEMBL4487	Homo sapiens	Inhibition	%	2.13
	8092658	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.16	CHEMBL4487	Homo sapiens	Inhibition	%	-0.16
	8093011	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.93	CHEMBL4487	Homo sapiens	Inhibition	%	2.93
	8093323	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.56	CHEMBL4487	Homo sapiens	Inhibition	%	2.56
	8093463	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.56	CHEMBL4487	Homo sapiens	Inhibition	%	-0.56
	8093687	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.89	CHEMBL4487	Homo sapiens	Inhibition	%	3.89
	8093826	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.15	CHEMBL4487	Homo sapiens	Inhibition	%	1.15
	8094170	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.49	CHEMBL4487	Homo sapiens	Inhibition	%	0.49
	8094350	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.09	CHEMBL4487	Homo sapiens	Inhibition	%	-1.09
	8094525	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.35	CHEMBL4487	Homo sapiens	Inhibition	%	1.35
	8094749	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.48	CHEMBL4487	Homo sapiens	Inhibition	%	0.48
	8094905	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.27	CHEMBL4487	Homo sapiens	Inhibition	%	0.27
	8095269	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-1.63	CHEMBL4487	Homo sapiens	Inhibition	%	-1.63
	8095472	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.94	CHEMBL4487	Homo sapiens	Inhibition	%	-0.94
	8095837	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.03	CHEMBL4487	Homo sapiens	Inhibition	%	3.03
	8095985	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.54	CHEMBL4487	Homo sapiens	Inhibition	%	1.54
	8096326	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.26	CHEMBL4487	Homo sapiens	Inhibition	%	2.26
	8096465	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.48	CHEMBL4487	Homo sapiens	Inhibition	%	1.48
	8096689	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.11	CHEMBL4487	Homo sapiens	Inhibition	%	0.11
	8096845	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.83	CHEMBL4487	Homo sapiens	Inhibition	%	3.83
	8096992	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.69	CHEMBL4487	Homo sapiens	Inhibition	%	-0.69
	8097216	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.1	CHEMBL4487	Homo sapiens	Inhibition	%	-1.1
	8097303	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.19	CHEMBL4487	Homo sapiens	Inhibition	%	1.19
	8097523	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.03	CHEMBL4487	Homo sapiens	Inhibition	%	2.03
	8097897	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	36.33	CHEMBL4487	Homo sapiens	Inhibition	%	36.33
	8098030	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.12	CHEMBL4487	Homo sapiens	Inhibition	%	-0.12
	8098374	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.38	CHEMBL4487	Homo sapiens	Inhibition	%	0.38
	8098554	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.44	CHEMBL4487	Homo sapiens	Inhibition	%	-0.44
	8098963	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.24	CHEMBL4487	Homo sapiens	Inhibition	%	2.24
	8099107	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.82	CHEMBL4487	Homo sapiens	Inhibition	%	0.82
	8099473	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.85	CHEMBL4487	Homo sapiens	Inhibition	%	0.85
	8099667	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.74	CHEMBL4487	Homo sapiens	Inhibition	%	0.74
	8100038	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.75	CHEMBL4487	Homo sapiens	Inhibition	%	1.75
	8100184	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.6	CHEMBL4487	Homo sapiens	Inhibition	%	2.6
	8100408	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.33	CHEMBL4487	Homo sapiens	Inhibition	%	0.33
	8100524	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.63	CHEMBL4487	Homo sapiens	Inhibition	%	2.63
	8100888	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.24	CHEMBL4487	Homo sapiens	Inhibition	%	0.24
	8101048	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.37	CHEMBL4487	Homo sapiens	Inhibition	%	2.37
	8101414	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.31	CHEMBL4487	Homo sapiens	Inhibition	%	-1.31
	8101599	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.84	CHEMBL4487	Homo sapiens	Inhibition	%	1.84
	8101852	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.94	CHEMBL4487	Homo sapiens	Inhibition	%	0.94
	8102231	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-3.16	CHEMBL4487	Homo sapiens	Inhibition	%	-3.16
	8102362	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.31	CHEMBL4487	Homo sapiens	Inhibition	%	-0.31
	8102586	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.97	CHEMBL4487	Homo sapiens	Inhibition	%	-0.97
	8102706	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.1	CHEMBL4487	Homo sapiens	Inhibition	%	0.1
	8102884	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.79	CHEMBL4487	Homo sapiens	Inhibition	%	-0.79
	8103108	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.42	CHEMBL4487	Homo sapiens	Inhibition	%	-0.42
	8103304	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.1	CHEMBL4487	Homo sapiens	Inhibition	%	1.1
	8103442	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.14	CHEMBL4487	Homo sapiens	Inhibition	%	0.14
	8103666	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.32	CHEMBL4487	Homo sapiens	Inhibition	%	0.32
	8103816	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.29	CHEMBL4487	Homo sapiens	Inhibition	%	1.29
	8104001	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.16	CHEMBL4487	Homo sapiens	Inhibition	%	0.16
	8104225	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.81	CHEMBL4487	Homo sapiens	Inhibition	%	-0.81
	8104373	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.47	CHEMBL4487	Homo sapiens	Inhibition	%	1.47
	8104743	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.86	CHEMBL4487	Homo sapiens	Inhibition	%	0.86
	8104857	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.65	CHEMBL4487	Homo sapiens	Inhibition	%	1.65
	8105221	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.15	CHEMBL4487	Homo sapiens	Inhibition	%	-0.15
	8105387	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.02	CHEMBL4487	Homo sapiens	Inhibition	%	3.02
	8105611	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.74	CHEMBL4487	Homo sapiens	Inhibition	%	1.74
	8105749	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.61	CHEMBL4487	Homo sapiens	Inhibition	%	-0.61
	8106029	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.19	CHEMBL4487	Homo sapiens	Inhibition	%	2.19
	8106194	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.74	CHEMBL4487	Homo sapiens	Inhibition	%	0.74
	8106418	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.45	CHEMBL4487	Homo sapiens	Inhibition	%	1.45
	8106574	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.55	CHEMBL4487	Homo sapiens	Inhibition	%	-0.55
	8106927	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.12	CHEMBL4487	Homo sapiens	Inhibition	%	0.12
	8107048	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.8	CHEMBL4487	Homo sapiens	Inhibition	%	-0.8
	8107444	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.71	CHEMBL4487	Homo sapiens	Inhibition	%	-0.71
	8107645	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	10.94	CHEMBL4487	Homo sapiens	Inhibition	%	10.94
	8108004	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.69	CHEMBL4487	Homo sapiens	Inhibition	%	0.69
	8108162	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.12	CHEMBL4487	Homo sapiens	Inhibition	%	0.12
	8108561	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.02	CHEMBL4487	Homo sapiens	Inhibition	%	0.02
	8108708	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.01	CHEMBL4487	Homo sapiens	Inhibition	%	3.01
	8109074	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.35	CHEMBL4487	Homo sapiens	Inhibition	%	-0.35
	8109188	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.68	CHEMBL4487	Homo sapiens	Inhibition	%	2.68
	8109412	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.4	CHEMBL4487	Homo sapiens	Inhibition	%	1.4
	8109542	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.01	CHEMBL4487	Homo sapiens	Inhibition	%	-0.01
	8109937	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.5	CHEMBL4487	Homo sapiens	Inhibition	%	2.5
	8110069	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.76	CHEMBL4487	Homo sapiens	Inhibition	%	1.76
	8110348	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.41	CHEMBL4487	Homo sapiens	Inhibition	%	1.41
	8110738	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.67	CHEMBL4487	Homo sapiens	Inhibition	%	1.67
	8110896	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.05	CHEMBL4487	Homo sapiens	Inhibition	%	-1.05
	8111243	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.53	CHEMBL4487	Homo sapiens	Inhibition	%	0.53
	8111370	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.35	CHEMBL4487	Homo sapiens	Inhibition	%	-0.35
	8111594	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.99	CHEMBL4487	Homo sapiens	Inhibition	%	1.99
	8111760	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-1.57	CHEMBL4487	Homo sapiens	Inhibition	%	-1.57
	8111965	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.94	CHEMBL4487	Homo sapiens	Inhibition	%	0.94
	8112189	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.06	CHEMBL4487	Homo sapiens	Inhibition	%	2.06
	8112326	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.35	CHEMBL4487	Homo sapiens	Inhibition	%	-1.35
	8112494	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.57	CHEMBL4487	Homo sapiens	Inhibition	%	0.57
	8112718	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.24	CHEMBL4487	Homo sapiens	Inhibition	%	3.24
	8112890	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.75	CHEMBL4487	Homo sapiens	Inhibition	%	-0.75
	8113042	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.81	CHEMBL4487	Homo sapiens	Inhibition	%	3.81
	8113266	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.23	CHEMBL4487	Homo sapiens	Inhibition	%	1.23
	8113402	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.7	CHEMBL4487	Homo sapiens	Inhibition	%	0.7
	8113750	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.47	CHEMBL4487	Homo sapiens	Inhibition	%	1.47
	8113866	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.9	CHEMBL4487	Homo sapiens	Inhibition	%	-0.9
	8114090	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.98	CHEMBL4487	Homo sapiens	Inhibition	%	-0.98
	8114266	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.38	CHEMBL4487	Homo sapiens	Inhibition	%	1.38
	8114398	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.6	CHEMBL4487	Homo sapiens	Inhibition	%	1.6
	8114622	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.79	CHEMBL4487	Homo sapiens	Inhibition	%	1.79
	8114674	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.09	CHEMBL4487	Homo sapiens	Inhibition	%	2.09
	8114898	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.97	CHEMBL4487	Homo sapiens	Inhibition	%	1.97
	8115064	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.88	CHEMBL4487	Homo sapiens	Inhibition	%	0.88
	8115229	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.34	CHEMBL4487	Homo sapiens	Inhibition	%	-1.34
	8115453	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.89	CHEMBL4487	Homo sapiens	Inhibition	%	-0.89
	8115573	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.26	CHEMBL4487	Homo sapiens	Inhibition	%	0.26
	8115930	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	16.59	CHEMBL4487	Homo sapiens	Inhibition	%	16.59
	8116089	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.4	CHEMBL4487	Homo sapiens	Inhibition	%	-1.4
	8116516	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.98	CHEMBL4487	Homo sapiens	Inhibition	%	1.98
	8116650	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.3	CHEMBL4487	Homo sapiens	Inhibition	%	-0.3
	8117046	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.78	CHEMBL4487	Homo sapiens	Inhibition	%	1.78
	8117217	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.34	CHEMBL4487	Homo sapiens	Inhibition	%	-2.34
	8117599	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.27	CHEMBL4487	Homo sapiens	Inhibition	%	2.27
	8117729	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.77	CHEMBL4487	Homo sapiens	Inhibition	%	0.77
	8118091	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.93	CHEMBL4487	Homo sapiens	Inhibition	%	0.93
	8118431	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.72	CHEMBL4487	Homo sapiens	Inhibition	%	2.72
	8118603	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.12	CHEMBL4487	Homo sapiens	Inhibition	%	3.12
	8118963	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.67	CHEMBL4487	Homo sapiens	Inhibition	%	1.67
	8119234	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.54	CHEMBL4487	Homo sapiens	Inhibition	%	1.54
	8119393	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.23	CHEMBL4487	Homo sapiens	Inhibition	%	1.23
	8119784	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.09	CHEMBL4487	Homo sapiens	Inhibition	%	-0.09
	8119903	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.56	CHEMBL4487	Homo sapiens	Inhibition	%	1.56
	8120127	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.25	CHEMBL4487	Homo sapiens	Inhibition	%	1.25
	8120266	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.68	CHEMBL4487	Homo sapiens	Inhibition	%	0.68
	8120426	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.42	CHEMBL4487	Homo sapiens	Inhibition	%	-0.42
	8120650	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.9	CHEMBL4487	Homo sapiens	Inhibition	%	-1.9
	8120851	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	13.47	CHEMBL4487	Homo sapiens	Inhibition	%	13.47
	8120979	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.91	CHEMBL4487	Homo sapiens	Inhibition	%	-1.91
	8121203	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.73	CHEMBL4487	Homo sapiens	Inhibition	%	-1.73
	8121375	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.85	CHEMBL4487	Homo sapiens	Inhibition	%	0.85
	8121542	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.84	CHEMBL4487	Homo sapiens	Inhibition	%	0.84
	8121766	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.54	CHEMBL4487	Homo sapiens	Inhibition	%	0.54
	8121929	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.42	CHEMBL4487	Homo sapiens	Inhibition	%	1.42
	8122050	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.12	CHEMBL4487	Homo sapiens	Inhibition	%	-0.12
	8122274	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	Inhibition	%	-1.0
	8122412	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.83	CHEMBL4487	Homo sapiens	Inhibition	%	1.83
	8122756	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.55	CHEMBL4487	Homo sapiens	Inhibition	%	2.55
	8122923	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.09	CHEMBL4487	Homo sapiens	Inhibition	%	2.09
	8123289	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.94	CHEMBL4487	Homo sapiens	Inhibition	%	1.94
	8123567	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.5	CHEMBL4487	Homo sapiens	Inhibition	%	1.5
	8123717	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.39	CHEMBL4487	Homo sapiens	Inhibition	%	2.39
	8123941	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.53	CHEMBL4487	Homo sapiens	Inhibition	%	1.53
	8124108	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.03	CHEMBL4487	Homo sapiens	Inhibition	%	-1.03
	8124451	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.0	CHEMBL4487	Homo sapiens	Inhibition	%	1.0
	8124590	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.11	CHEMBL4487	Homo sapiens	Inhibition	%	-0.11
	8124979	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.35	CHEMBL4487	Homo sapiens	Inhibition	%	-1.35
	8125180	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.26	CHEMBL4487	Homo sapiens	Inhibition	%	1.26
	8125534	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.8	CHEMBL4487	Homo sapiens	Inhibition	%	-0.8
	8125702	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.99	CHEMBL4487	Homo sapiens	Inhibition	%	0.99
	8126090	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.1	CHEMBL4487	Homo sapiens	Inhibition	%	-1.1
	8126254	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.45	CHEMBL4487	Homo sapiens	Inhibition	%	2.45
	8126593	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.68	CHEMBL4487	Homo sapiens	Inhibition	%	-1.68
	8126729	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.87	CHEMBL4487	Homo sapiens	Inhibition	%	1.87
	8126953	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.66	CHEMBL4487	Homo sapiens	Inhibition	%	2.66
	8127075	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.19	CHEMBL4487	Homo sapiens	Inhibition	%	2.19
	8127242	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.6	CHEMBL4487	Homo sapiens	Inhibition	%	1.6
	8127466	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.97	CHEMBL4487	Homo sapiens	Inhibition	%	1.97
	8127608	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.77	CHEMBL4487	Homo sapiens	Inhibition	%	1.77
	8127896	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.49	CHEMBL4487	Homo sapiens	Inhibition	%	1.49
	8128272	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.73	CHEMBL4487	Homo sapiens	Inhibition	%	1.73
	8128439	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.99	CHEMBL4487	Homo sapiens	Inhibition	%	-0.99
	8128782	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.62	CHEMBL4487	Homo sapiens	Inhibition	%	2.62
	8128919	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.79	CHEMBL4487	Homo sapiens	Inhibition	%	0.79
	8129143	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	Inhibition	%	-1.0
	8129314	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.68	CHEMBL4487	Homo sapiens	Inhibition	%	-1.68
	8129503	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.44	CHEMBL4487	Homo sapiens	Inhibition	%	2.44
	8129866	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.23	CHEMBL4487	Homo sapiens	Inhibition	%	-0.23
	8130027	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.24	CHEMBL4487	Homo sapiens	Inhibition	%	0.24
	8130423	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.04	CHEMBL4487	Homo sapiens	Inhibition	%	-2.04
	8130583	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.19	CHEMBL4487	Homo sapiens	Inhibition	%	1.19
	8130923	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.73	CHEMBL4487	Homo sapiens	Inhibition	%	1.73
	8131286	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.72	CHEMBL4487	Homo sapiens	Inhibition	%	1.72
	8131406	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.52	CHEMBL4487	Homo sapiens	Inhibition	%	3.52
	8131797	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.27	CHEMBL4487	Homo sapiens	Inhibition	%	2.27
	8131938	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.77	CHEMBL4487	Homo sapiens	Inhibition	%	1.77
	8132162	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.5	CHEMBL4487	Homo sapiens	Inhibition	%	1.5
	8132224	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.12	CHEMBL4487	Homo sapiens	Inhibition	%	1.12
	8132595	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.38	CHEMBL4487	Homo sapiens	Inhibition	%	0.38
	8132763	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.07	CHEMBL4487	Homo sapiens	Inhibition	%	0.07
	8132987	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.55	CHEMBL4487	Homo sapiens	Inhibition	%	-0.55
	8133108	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.78	CHEMBL4487	Homo sapiens	Inhibition	%	0.78
	8133470	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.09	CHEMBL4487	Homo sapiens	Inhibition	%	2.09
	8133642	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.82	CHEMBL4487	Homo sapiens	Inhibition	%	-2.82
	8133822	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.16	CHEMBL4487	Homo sapiens	Inhibition	%	0.16
	8134046	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.51	CHEMBL4487	Homo sapiens	Inhibition	%	1.51
	8134194	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.02	CHEMBL4487	Homo sapiens	Inhibition	%	-2.02
	8134354	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.87	CHEMBL4487	Homo sapiens	Inhibition	%	-0.87
	8134578	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.23	CHEMBL4487	Homo sapiens	Inhibition	%	0.23
	8134762	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.89	CHEMBL4487	Homo sapiens	Inhibition	%	-1.89
	8134922	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.41	CHEMBL4487	Homo sapiens	Inhibition	%	3.41
	8135146	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.95	CHEMBL4487	Homo sapiens	Inhibition	%	1.95
	8135261	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.12	CHEMBL4487	Homo sapiens	Inhibition	%	1.12
	8135626	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.81	CHEMBL4487	Homo sapiens	Inhibition	%	1.81
	8135747	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.93	CHEMBL4487	Homo sapiens	Inhibition	%	1.93
	8135971	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.24	CHEMBL4487	Homo sapiens	Inhibition	%	3.24
	8136139	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.74	CHEMBL4487	Homo sapiens	Inhibition	%	1.74
	8136507	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.45	CHEMBL4487	Homo sapiens	Inhibition	%	2.45
	8136573	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.63	CHEMBL4487	Homo sapiens	Inhibition	%	1.63
	8136797	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.77	CHEMBL4487	Homo sapiens	Inhibition	%	0.77
	8136932	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.48	CHEMBL4487	Homo sapiens	Inhibition	%	0.48
	8137319	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.12	CHEMBL4487	Homo sapiens	Inhibition	%	0.12
	8137439	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.67	CHEMBL4487	Homo sapiens	Inhibition	%	0.67
	8137811	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.33	CHEMBL4487	Homo sapiens	Inhibition	%	0.33
	8137977	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.11	CHEMBL4487	Homo sapiens	Inhibition	%	-2.11
	8138380	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.05	CHEMBL4487	Homo sapiens	Inhibition	%	-0.05
	8138528	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.84	CHEMBL4487	Homo sapiens	Inhibition	%	-0.84
	8138910	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-1.68	CHEMBL4487	Homo sapiens	Inhibition	%	-1.68
	8139095	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-3.37	CHEMBL4487	Homo sapiens	Inhibition	%	-3.37
	8139478	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.95	CHEMBL4487	Homo sapiens	Inhibition	%	2.95
	8139592	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.24	CHEMBL4487	Homo sapiens	Inhibition	%	1.24
	8139816	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.28	CHEMBL4487	Homo sapiens	Inhibition	%	1.28
	8139957	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.04	CHEMBL4487	Homo sapiens	Inhibition	%	2.04
	8140304	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.09	CHEMBL4487	Homo sapiens	Inhibition	%	3.09
	8140463	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.26	CHEMBL4487	Homo sapiens	Inhibition	%	1.26
	8140830	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.56	CHEMBL4487	Homo sapiens	Inhibition	%	2.56
	8141132	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.89	CHEMBL4487	Homo sapiens	Inhibition	%	0.89
	8141262	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.06	CHEMBL4487	Homo sapiens	Inhibition	%	-0.06
	8141646	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-0.31	CHEMBL4487	Homo sapiens	Inhibition	%	-0.31
	8141765	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.52	CHEMBL4487	Homo sapiens	Inhibition	%	1.52
	8141989	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.05	CHEMBL4487	Homo sapiens	Inhibition	%	-0.05
	8142150	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.29	CHEMBL4487	Homo sapiens	Inhibition	%	-0.29
	8142318	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.55	CHEMBL4487	Homo sapiens	Inhibition	%	-1.55
	8142542	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.54	CHEMBL4487	Homo sapiens	Inhibition	%	-1.54
	8142718	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.1	CHEMBL4487	Homo sapiens	Inhibition	%	-0.1
	8142867	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.39	CHEMBL4487	Homo sapiens	Inhibition	%	-1.39
	8143091	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.39	CHEMBL4487	Homo sapiens	Inhibition	%	-3.39
	8143246	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.83	CHEMBL4487	Homo sapiens	Inhibition	%	0.83
	8143433	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.87	CHEMBL4487	Homo sapiens	Inhibition	%	1.87
	8143657	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.49	CHEMBL4487	Homo sapiens	Inhibition	%	1.49
	8143816	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.38	CHEMBL4487	Homo sapiens	Inhibition	%	1.38
	8144154	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.93	CHEMBL4487	Homo sapiens	Inhibition	%	0.93
	8144293	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.89	CHEMBL4487	Homo sapiens	Inhibition	%	2.89
	8144647	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.5	CHEMBL4487	Homo sapiens	Inhibition	%	3.5
	8144800	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.46	CHEMBL4487	Homo sapiens	Inhibition	%	1.46
	8145024	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.63	CHEMBL4487	Homo sapiens	Inhibition	%	0.63
	8145161	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.7	CHEMBL4487	Homo sapiens	Inhibition	%	2.7
	8145474	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.19	CHEMBL4487	Homo sapiens	Inhibition	%	1.19
	8145598	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.42	CHEMBL4487	Homo sapiens	Inhibition	%	0.42
	8145822	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.03	CHEMBL4487	Homo sapiens	Inhibition	%	-0.03
	8145983	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.79	CHEMBL4487	Homo sapiens	Inhibition	%	1.79
	8146327	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	10.79	CHEMBL4487	Homo sapiens	Inhibition	%	10.79
	8146487	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.11	CHEMBL4487	Homo sapiens	Inhibition	%	0.11
	8146878	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.14	CHEMBL4487	Homo sapiens	Inhibition	%	-2.14
	8147047	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.51	CHEMBL4487	Homo sapiens	Inhibition	%	-0.51
	8147413	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.33	CHEMBL4487	Homo sapiens	Inhibition	%	0.33
	8147566	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.22	CHEMBL4487	Homo sapiens	Inhibition	%	0.22
	8147977	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.7	CHEMBL4487	Homo sapiens	Inhibition	%	1.7
	8148135	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.7	CHEMBL4487	Homo sapiens	Inhibition	%	1.7
	8148473	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.63	CHEMBL4487	Homo sapiens	Inhibition	%	1.63
	8148612	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.02	CHEMBL4487	Homo sapiens	Inhibition	%	1.02
	8148836	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.33	CHEMBL4487	Homo sapiens	Inhibition	%	2.33
	8148974	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.27	CHEMBL4487	Homo sapiens	Inhibition	%	2.27
	8149357	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.62	CHEMBL4487	Homo sapiens	Inhibition	%	0.62
	8149491	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.71	CHEMBL4487	Homo sapiens	Inhibition	%	3.71
	8149813	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.99	CHEMBL4487	Homo sapiens	Inhibition	%	1.99
	8150162	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.17	CHEMBL4487	Homo sapiens	Inhibition	%	0.17
	8150322	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.61	CHEMBL4487	Homo sapiens	Inhibition	%	1.61
	8150666	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.18	CHEMBL4487	Homo sapiens	Inhibition	%	0.18
	8150831	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.88	CHEMBL4487	Homo sapiens	Inhibition	%	1.88
	8151055	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.11	CHEMBL4487	Homo sapiens	Inhibition	%	2.11
	8151218	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.3	CHEMBL4487	Homo sapiens	Inhibition	%	-3.3
	8151395	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.53	CHEMBL4487	Homo sapiens	Inhibition	%	-0.53
	8151757	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.77	CHEMBL4487	Homo sapiens	Inhibition	%	0.77
	8151911	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.91	CHEMBL4487	Homo sapiens	Inhibition	%	0.91
	8152135	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.8	CHEMBL4487	Homo sapiens	Inhibition	%	-0.8
	8152323	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.99	CHEMBL4487	Homo sapiens	Inhibition	%	1.99
	8152481	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.76	CHEMBL4487	Homo sapiens	Inhibition	%	0.76
	8152705	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.87	CHEMBL4487	Homo sapiens	Inhibition	%	2.87
	8152819	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.58	CHEMBL4487	Homo sapiens	Inhibition	%	1.58
	8153182	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.62	CHEMBL4487	Homo sapiens	Inhibition	%	0.62
	8153319	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.2	CHEMBL4487	Homo sapiens	Inhibition	%	2.2
	8153543	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.6	CHEMBL4487	Homo sapiens	Inhibition	%	3.6
	8153700	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.16	CHEMBL4487	Homo sapiens	Inhibition	%	0.16
	8153833	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.98	CHEMBL4487	Homo sapiens	Inhibition	%	1.98
	8154057	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.75	CHEMBL4487	Homo sapiens	Inhibition	%	2.75
	8154154	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.98	CHEMBL4487	Homo sapiens	Inhibition	%	1.98
	8154504	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.57	CHEMBL4487	Homo sapiens	Inhibition	%	0.57
	8154663	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.68	CHEMBL4487	Homo sapiens	Inhibition	%	0.68
	8154887	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.72	CHEMBL4487	Homo sapiens	Inhibition	%	1.72
	8155007	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.01	CHEMBL4487	Homo sapiens	Inhibition	%	0.01
	8155407	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.44	CHEMBL4487	Homo sapiens	Inhibition	%	-2.44
	8155568	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.55	CHEMBL4487	Homo sapiens	Inhibition	%	-4.55
	8155746	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.85	CHEMBL4487	Homo sapiens	Inhibition	%	1.85
	8155970	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.62	CHEMBL4487	Homo sapiens	Inhibition	%	1.62
	8156108	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.07	CHEMBL4487	Homo sapiens	Inhibition	%	-0.07
	8156320	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.31	CHEMBL4487	Homo sapiens	Inhibition	%	2.31
	8156544	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.95	CHEMBL4487	Homo sapiens	Inhibition	%	1.95
	8156694	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8157061	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.78	CHEMBL4487	Homo sapiens	Inhibition	%	1.78
	8157181	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.78	CHEMBL4487	Homo sapiens	Inhibition	%	1.78
	8157546	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.46	CHEMBL4487	Homo sapiens	Inhibition	%	1.46
	8157676	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.3	CHEMBL4487	Homo sapiens	Inhibition	%	2.3
	8157900	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.63	CHEMBL4487	Homo sapiens	Inhibition	%	1.63
	8158061	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.32	CHEMBL4487	Homo sapiens	Inhibition	%	0.32
	8158311	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.16	CHEMBL4487	Homo sapiens	Inhibition	%	2.16
	8158693	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.96	CHEMBL4487	Homo sapiens	Inhibition	%	0.96
	8158862	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.42	CHEMBL4487	Homo sapiens	Inhibition	%	0.42
	8159221	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.91	CHEMBL4487	Homo sapiens	Inhibition	%	1.91
	8159341	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.32	CHEMBL4487	Homo sapiens	Inhibition	%	2.32
	8159565	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.52	CHEMBL4487	Homo sapiens	Inhibition	%	-0.52
	8159696	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.59	CHEMBL4487	Homo sapiens	Inhibition	%	2.59
	8160061	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.63	CHEMBL4487	Homo sapiens	Inhibition	%	-0.63
	8160198	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.25	CHEMBL4487	Homo sapiens	Inhibition	%	1.25
	8160572	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.84	CHEMBL4487	Homo sapiens	Inhibition	%	-0.84
	8160866	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.97	CHEMBL4487	Homo sapiens	Inhibition	%	1.97
	8161016	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.52	CHEMBL4487	Homo sapiens	Inhibition	%	2.52
	8161383	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.04	CHEMBL4487	Homo sapiens	Inhibition	%	4.04
	8161508	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.55	CHEMBL4487	Homo sapiens	Inhibition	%	1.55
	8161732	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.94	CHEMBL4487	Homo sapiens	Inhibition	%	1.94
	8161870	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.81	CHEMBL4487	Homo sapiens	Inhibition	%	2.81
	8162224	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.82	CHEMBL4487	Homo sapiens	Inhibition	%	1.82
	8162384	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.22	CHEMBL4487	Homo sapiens	Inhibition	%	1.22
	8162637	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.0	CHEMBL4487	Homo sapiens	Inhibition	%	1.0
	8162861	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.51	CHEMBL4487	Homo sapiens	Inhibition	%	1.51
	8163009	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.5	CHEMBL4487	Homo sapiens	Inhibition	%	2.5
	8163178	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.22	CHEMBL4487	Homo sapiens	Inhibition	%	2.22
	8163402	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.12	CHEMBL4487	Homo sapiens	Inhibition	%	0.12
	8163536	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.46	CHEMBL4487	Homo sapiens	Inhibition	%	2.46
	8163883	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.49	CHEMBL4487	Homo sapiens	Inhibition	%	0.49
	8164017	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.49	CHEMBL4487	Homo sapiens	Inhibition	%	2.49
	8164381	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.56	CHEMBL4487	Homo sapiens	Inhibition	%	-0.56
	8164536	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.76	CHEMBL4487	Homo sapiens	Inhibition	%	0.76
	8164760	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.67	CHEMBL4487	Homo sapiens	Inhibition	%	1.67
	8164904	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.18	CHEMBL4487	Homo sapiens	Inhibition	%	-0.18
	8165198	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.92	CHEMBL4487	Homo sapiens	Inhibition	%	0.92
	8165339	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.58	CHEMBL4487	Homo sapiens	Inhibition	%	1.58
	8165563	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.74	CHEMBL4487	Homo sapiens	Inhibition	%	1.74
	8165706	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.37	CHEMBL4487	Homo sapiens	Inhibition	%	3.37
	8166056	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.62	CHEMBL4487	Homo sapiens	Inhibition	%	1.62
	8166194	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8166418	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.54	CHEMBL4487	Homo sapiens	Inhibition	%	1.54
	8166548	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.18	CHEMBL4487	Homo sapiens	Inhibition	%	2.18
	8166873	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.21	CHEMBL4487	Homo sapiens	Inhibition	%	3.21
	8167185	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.41	CHEMBL4487	Homo sapiens	Inhibition	%	-0.41
	8167326	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.68	CHEMBL4487	Homo sapiens	Inhibition	%	4.68
	8167714	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.16	CHEMBL4487	Homo sapiens	Inhibition	%	1.16
	8167847	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.1	CHEMBL4487	Homo sapiens	Inhibition	%	3.1
	8168195	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.87	CHEMBL4487	Homo sapiens	Inhibition	%	-0.87
	8168336	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.33	CHEMBL4487	Homo sapiens	Inhibition	%	3.33
	8168560	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.25	CHEMBL4487	Homo sapiens	Inhibition	%	2.25
	8168696	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.36	CHEMBL4487	Homo sapiens	Inhibition	%	0.36
	8169084	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.52	CHEMBL4487	Homo sapiens	Inhibition	%	3.52
	8169226	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.62	CHEMBL4487	Homo sapiens	Inhibition	%	1.62
	8169530	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.69	CHEMBL4487	Homo sapiens	Inhibition	%	1.69
	8169888	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.21	CHEMBL4487	Homo sapiens	Inhibition	%	2.21
	8170033	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.1	CHEMBL4487	Homo sapiens	Inhibition	%	2.1
	8170382	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.44	CHEMBL4487	Homo sapiens	Inhibition	%	2.44
	8170746	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.42	CHEMBL4487	Homo sapiens	Inhibition	%	2.42
	8170881	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.52	CHEMBL4487	Homo sapiens	Inhibition	%	1.52
	8171078	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.06	CHEMBL4487	Homo sapiens	Inhibition	%	1.06
	8171302	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.97	CHEMBL4487	Homo sapiens	Inhibition	%	0.97
	8171519	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.34	CHEMBL4487	Homo sapiens	Inhibition	%	0.34
	8171660	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.44	CHEMBL4487	Homo sapiens	Inhibition	%	2.44
	8172037	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.05	CHEMBL4487	Homo sapiens	Inhibition	%	0.05
	8172169	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.8	CHEMBL4487	Homo sapiens	Inhibition	%	3.8
	8172393	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	0.87	CHEMBL4487	Homo sapiens	Inhibition	%	0.87
	8172521	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.03	CHEMBL4487	Homo sapiens	Inhibition	%	-0.03
	8172887	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.24	CHEMBL4487	Homo sapiens	Inhibition	%	2.24
	8173023	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.52	CHEMBL4487	Homo sapiens	Inhibition	%	-1.52
	8173247	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.15	CHEMBL4487	Homo sapiens	Inhibition	%	-1.15
	8173412	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.04	CHEMBL4487	Homo sapiens	Inhibition	%	3.04
	8173553	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8173777	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.5	CHEMBL4487	Homo sapiens	Inhibition	%	2.5
	8173864	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.34	CHEMBL4487	Homo sapiens	Inhibition	%	1.34
	8174220	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.48	CHEMBL4487	Homo sapiens	Inhibition	%	2.48
	8174368	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.99	CHEMBL4487	Homo sapiens	Inhibition	%	0.99
	8174592	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.76	CHEMBL4487	Homo sapiens	Inhibition	%	2.76
	8174714	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.43	CHEMBL4487	Homo sapiens	Inhibition	%	1.43
	8175081	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	12.73	CHEMBL4487	Homo sapiens	Inhibition	%	12.73
	8175217	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.06	CHEMBL4487	Homo sapiens	Inhibition	%	1.06
	8175441	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.9	CHEMBL4487	Homo sapiens	Inhibition	%	0.9
	8175473	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.82	CHEMBL4487	Homo sapiens	Inhibition	%	1.82
	8175697	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8175860	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.68	CHEMBL4487	Homo sapiens	Inhibition	%	0.68
	8176013	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.48	CHEMBL4487	Homo sapiens	Inhibition	%	3.48
	8176237	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.24	CHEMBL4487	Homo sapiens	Inhibition	%	3.24
	8176386	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.67	CHEMBL4487	Homo sapiens	Inhibition	%	0.67
	8176742	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.53	CHEMBL4487	Homo sapiens	Inhibition	%	1.53
	8176872	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.68	CHEMBL4487	Homo sapiens	Inhibition	%	-0.68
	8177096	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.37	CHEMBL4487	Homo sapiens	Inhibition	%	0.37
	8177238	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.28	CHEMBL4487	Homo sapiens	Inhibition	%	2.28
	8177600	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.43	CHEMBL4487	Homo sapiens	Inhibition	%	1.43
	8177764	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.37	CHEMBL4487	Homo sapiens	Inhibition	%	2.37
	8178128	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8178216	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.15	CHEMBL4487	Homo sapiens	Inhibition	%	3.15
	8178440	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.72	CHEMBL4487	Homo sapiens	Inhibition	%	1.72
	8178567	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.99	CHEMBL4487	Homo sapiens	Inhibition	%	0.99
	8178940	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.58	CHEMBL4487	Homo sapiens	Inhibition	%	1.58
	8179063	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.21	CHEMBL4487	Homo sapiens	Inhibition	%	1.21
	8179287	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.91	CHEMBL4487	Homo sapiens	Inhibition	%	1.91
	8179431	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.01	CHEMBL4487	Homo sapiens	Inhibition	%	2.01
	8179792	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.72	CHEMBL4487	Homo sapiens	Inhibition	%	0.72
	8180049	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.19	CHEMBL4487	Homo sapiens	Inhibition	%	1.19
	8180203	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.06	CHEMBL4487	Homo sapiens	Inhibition	%	1.06
	8180583	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.52	CHEMBL4487	Homo sapiens	Inhibition	%	4.52
	8180731	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-0.61	CHEMBL4487	Homo sapiens	Inhibition	%	-0.61
	8180955	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.6	CHEMBL4487	Homo sapiens	Inhibition	%	0.6
	8181088	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.82	CHEMBL4487	Homo sapiens	Inhibition	%	2.82
	8181443	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.56	CHEMBL4487	Homo sapiens	Inhibition	%	-1.56
	8181583	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.67	CHEMBL4487	Homo sapiens	Inhibition	%	2.67
	8181946	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.51	CHEMBL4487	Homo sapiens	Inhibition	%	3.51
	8182109	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.67	CHEMBL4487	Homo sapiens	Inhibition	%	1.67
	8182333	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.07	CHEMBL4487	Homo sapiens	Inhibition	%	2.07
	8182473	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.92	CHEMBL4487	Homo sapiens	Inhibition	%	1.92
	8182789	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.31	CHEMBL4487	Homo sapiens	Inhibition	%	-0.31
	8182911	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.32	CHEMBL4487	Homo sapiens	Inhibition	%	2.32
	8183135	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.24	CHEMBL4487	Homo sapiens	Inhibition	%	2.24
	8183284	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.79	CHEMBL4487	Homo sapiens	Inhibition	%	2.79
	8183637	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.32	CHEMBL4487	Homo sapiens	Inhibition	%	1.32
	8183779	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.49	CHEMBL4487	Homo sapiens	Inhibition	%	2.49
	8184139	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.92	CHEMBL4487	Homo sapiens	Inhibition	%	0.92
	8184405	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.25	CHEMBL4487	Homo sapiens	Inhibition	%	2.25
	8184552	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.06	CHEMBL4487	Homo sapiens	Inhibition	%	-0.06
	8184776	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.55	CHEMBL4487	Homo sapiens	Inhibition	%	-0.55
	8184933	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.46	CHEMBL4487	Homo sapiens	Inhibition	%	1.46
	8185306	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.34	CHEMBL4487	Homo sapiens	Inhibition	%	-0.34
	8185437	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.56	CHEMBL4487	Homo sapiens	Inhibition	%	2.56
	8185792	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.06	CHEMBL4487	Homo sapiens	Inhibition	%	-1.06
	8185931	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.44	CHEMBL4487	Homo sapiens	Inhibition	%	1.44
	8186155	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.41	CHEMBL4487	Homo sapiens	Inhibition	%	2.41
	8186296	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.93	CHEMBL4487	Homo sapiens	Inhibition	%	1.93
	8186684	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.61	CHEMBL4487	Homo sapiens	Inhibition	%	1.61
	8186823	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.47	CHEMBL4487	Homo sapiens	Inhibition	%	2.47
	8187145	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.07	CHEMBL4487	Homo sapiens	Inhibition	%	0.07
	8187493	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.37	CHEMBL4487	Homo sapiens	Inhibition	%	4.37
	8187641	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.98	CHEMBL4487	Homo sapiens	Inhibition	%	1.98
	8187994	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.42	CHEMBL4487	Homo sapiens	Inhibition	%	1.42
	8188137	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.72	CHEMBL4487	Homo sapiens	Inhibition	%	0.72
	8188361	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.37	CHEMBL4487	Homo sapiens	Inhibition	%	1.37
	8188496	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.07	CHEMBL4487	Homo sapiens	Inhibition	%	-0.07
	8188770	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8189142	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.56	CHEMBL4487	Homo sapiens	Inhibition	%	-0.56
	8189298	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.5	CHEMBL4487	Homo sapiens	Inhibition	%	2.5
	8189671	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.13	CHEMBL4487	Homo sapiens	Inhibition	%	-0.13
	8189803	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.71	CHEMBL4487	Homo sapiens	Inhibition	%	2.71
	8190027	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.48	CHEMBL4487	Homo sapiens	Inhibition	%	1.48
	8190159	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.92	CHEMBL4487	Homo sapiens	Inhibition	%	1.92
	8190523	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.07	CHEMBL4487	Homo sapiens	Inhibition	%	2.07
	8190660	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.93	CHEMBL4487	Homo sapiens	Inhibition	%	0.93
	8191048	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.57	CHEMBL4487	Homo sapiens	Inhibition	%	1.57
	8191186	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.79	CHEMBL4487	Homo sapiens	Inhibition	%	1.79
	8191410	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.9	CHEMBL4487	Homo sapiens	Inhibition	%	2.9
	8191506	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.24	CHEMBL4487	Homo sapiens	Inhibition	%	-0.24
	8191852	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.6	CHEMBL4487	Homo sapiens	Inhibition	%	2.6
	8192001	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.1	CHEMBL4487	Homo sapiens	Inhibition	%	2.1
	8192225	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.76	CHEMBL4487	Homo sapiens	Inhibition	%	1.76
	8192354	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.61	CHEMBL4487	Homo sapiens	Inhibition	%	0.61
	8192722	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.06	CHEMBL4487	Homo sapiens	Inhibition	%	2.06
	8192858	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.47	CHEMBL4487	Homo sapiens	Inhibition	%	-0.47
	8193082	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.62	CHEMBL4487	Homo sapiens	Inhibition	%	-0.62
	8193130	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.59	CHEMBL4487	Homo sapiens	Inhibition	%	3.59
	8193354	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.6	CHEMBL4487	Homo sapiens	Inhibition	%	0.6
	8193499	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.45	CHEMBL4487	Homo sapiens	Inhibition	%	-0.45
	8193656	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.76	CHEMBL4487	Homo sapiens	Inhibition	%	1.76
	8193880	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.04	CHEMBL4487	Homo sapiens	Inhibition	%	2.04
	8194029	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.37	CHEMBL4487	Homo sapiens	Inhibition	%	-2.37
	8194384	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.81	CHEMBL4487	Homo sapiens	Inhibition	%	1.81
	8194515	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.48	CHEMBL4487	Homo sapiens	Inhibition	%	2.48
	8194882	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.41	CHEMBL4487	Homo sapiens	Inhibition	%	2.41
	8195015	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.03	CHEMBL4487	Homo sapiens	Inhibition	%	2.03
	8195239	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.52	CHEMBL4487	Homo sapiens	Inhibition	%	2.52
	8195403	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.29	CHEMBL4487	Homo sapiens	Inhibition	%	1.29
	8195766	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.61	CHEMBL4487	Homo sapiens	Inhibition	%	2.61
	8195864	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.86	CHEMBL4487	Homo sapiens	Inhibition	%	0.86
	8196088	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.19	CHEMBL4487	Homo sapiens	Inhibition	%	0.19
	8196205	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.47	CHEMBL4487	Homo sapiens	Inhibition	%	2.47
	8196579	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.41	CHEMBL4487	Homo sapiens	Inhibition	%	2.41
	8196707	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.95	CHEMBL4487	Homo sapiens	Inhibition	%	0.95
	8196931	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.62	CHEMBL4487	Homo sapiens	Inhibition	%	0.62
	8197072	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.02	CHEMBL4487	Homo sapiens	Inhibition	%	2.02
	8197433	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.03	CHEMBL4487	Homo sapiens	Inhibition	%	0.03
	8197708	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.36	CHEMBL4487	Homo sapiens	Inhibition	%	1.36
	8197848	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-1.4	CHEMBL4487	Homo sapiens	Inhibition	%	-1.4
	8198229	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.06	CHEMBL4487	Homo sapiens	Inhibition	%	3.06
	8198367	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.78	CHEMBL4487	Homo sapiens	Inhibition	%	-1.78
	8198721	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.35	CHEMBL4487	Homo sapiens	Inhibition	%	2.35
	8198852	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.34	CHEMBL4487	Homo sapiens	Inhibition	%	2.34
	8199076	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.81	CHEMBL4487	Homo sapiens	Inhibition	%	1.81
	8199224	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.07	CHEMBL4487	Homo sapiens	Inhibition	%	2.07
	8199582	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.86	CHEMBL4487	Homo sapiens	Inhibition	%	1.86
	8199745	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	0.81	CHEMBL4487	Homo sapiens	Inhibition	%	0.81
	8200107	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.79	CHEMBL4487	Homo sapiens	Inhibition	%	2.79
	8200435	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.12	CHEMBL4487	Homo sapiens	Inhibition	%	1.12
	8200550	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.26	CHEMBL4487	Homo sapiens	Inhibition	%	2.26
	8200774	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.22	CHEMBL4487	Homo sapiens	Inhibition	%	2.22
	8200924	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.9	CHEMBL4487	Homo sapiens	Inhibition	%	1.9
	8201278	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.03	CHEMBL4487	Homo sapiens	Inhibition	%	0.03
	8201413	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.08	CHEMBL4487	Homo sapiens	Inhibition	%	1.08
	8201770	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.29	CHEMBL4487	Homo sapiens	Inhibition	%	-1.29
	8202049	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.44	CHEMBL4487	Homo sapiens	Inhibition	%	1.44
	8202189	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-1.31	CHEMBL4487	Homo sapiens	Inhibition	%	-1.31
	8202413	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.22	CHEMBL4487	Homo sapiens	Inhibition	%	-2.22
	8202580	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.6	CHEMBL4487	Homo sapiens	Inhibition	%	1.6
	8202705	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.23	CHEMBL4487	Homo sapiens	Inhibition	%	1.23
	8202929	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.38	CHEMBL4487	Homo sapiens	Inhibition	%	1.38
	8203059	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.42	CHEMBL4487	Homo sapiens	Inhibition	%	3.42
	8203414	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.47	CHEMBL4487	Homo sapiens	Inhibition	%	3.47
	8203560	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.52	CHEMBL4487	Homo sapiens	Inhibition	%	1.52
	8203784	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.39	CHEMBL4487	Homo sapiens	Inhibition	%	1.39
	8203918	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.71	CHEMBL4487	Homo sapiens	Inhibition	%	2.71
	8204084	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-0.11	CHEMBL4487	Homo sapiens	Inhibition	%	-0.11
	8204308	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.96	CHEMBL4487	Homo sapiens	Inhibition	%	0.96
	8204445	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.37	CHEMBL4487	Homo sapiens	Inhibition	%	3.37
	8204774	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.15	CHEMBL4487	Homo sapiens	Inhibition	%	-0.15
	8205113	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.35	CHEMBL4487	Homo sapiens	Inhibition	%	1.35
	8205262	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.69	CHEMBL4487	Homo sapiens	Inhibition	%	3.69
	8205622	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.86	CHEMBL4487	Homo sapiens	Inhibition	%	0.86
	8205761	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.46	CHEMBL4487	Homo sapiens	Inhibition	%	0.46
	8205985	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.76	CHEMBL4487	Homo sapiens	Inhibition	%	1.76
	8206117	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.27	CHEMBL4487	Homo sapiens	Inhibition	%	-1.27
	8206393	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.87	CHEMBL4487	Homo sapiens	Inhibition	%	1.87
	8206760	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.94	CHEMBL4487	Homo sapiens	Inhibition	%	-1.94
	8206940	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.48	CHEMBL4487	Homo sapiens	Inhibition	%	1.48
	8207290	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8207420	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.13	CHEMBL4487	Homo sapiens	Inhibition	%	3.13
	8207644	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.36	CHEMBL4487	Homo sapiens	Inhibition	%	2.36
	8207776	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.15	CHEMBL4487	Homo sapiens	Inhibition	%	3.15
	8208145	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.34	CHEMBL4487	Homo sapiens	Inhibition	%	0.34
	8208277	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.66	CHEMBL4487	Homo sapiens	Inhibition	%	2.66
	8208667	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-0.2	CHEMBL4487	Homo sapiens	Inhibition	%	-0.2
	8208800	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.71	CHEMBL4487	Homo sapiens	Inhibition	%	2.71
	8209024	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.23	CHEMBL4487	Homo sapiens	Inhibition	%	3.23
	8209129	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	Inhibition	%	-1.0
	8209469	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.82	CHEMBL4487	Homo sapiens	Inhibition	%	1.82
	8209619	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.04	CHEMBL4487	Homo sapiens	Inhibition	%	3.04
	8209843	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.52	CHEMBL4487	Homo sapiens	Inhibition	%	1.52
	8209979	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.74	CHEMBL4487	Homo sapiens	Inhibition	%	1.74
	8210344	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.56	CHEMBL4487	Homo sapiens	Inhibition	%	1.56
	8210480	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.22	CHEMBL4487	Homo sapiens	Inhibition	%	-2.22
	8210739	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.55	CHEMBL4487	Homo sapiens	Inhibition	%	1.55
	8211107	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.91	CHEMBL4487	Homo sapiens	Inhibition	%	1.91
	8211277	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8211624	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.78	CHEMBL4487	Homo sapiens	Inhibition	%	1.78
	8211977	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.87	CHEMBL4487	Homo sapiens	Inhibition	%	3.87
	8212109	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.01	CHEMBL4487	Homo sapiens	Inhibition	%	3.01
	8212474	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.33	CHEMBL4487	Homo sapiens	Inhibition	%	1.33
	8212607	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.63	CHEMBL4487	Homo sapiens	Inhibition	%	1.63
	8212831	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.54	CHEMBL4487	Homo sapiens	Inhibition	%	2.54
	8213001	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.46	CHEMBL4487	Homo sapiens	Inhibition	%	2.46
	8213354	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.18	CHEMBL4487	Homo sapiens	Inhibition	%	2.18
	8213458	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.6	CHEMBL4487	Homo sapiens	Inhibition	%	-0.6
	8213682	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.89	CHEMBL4487	Homo sapiens	Inhibition	%	-1.89
	8213795	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.66	CHEMBL4487	Homo sapiens	Inhibition	%	1.66
	8214166	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.07	CHEMBL4487	Homo sapiens	Inhibition	%	2.07
	8214303	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.59	CHEMBL4487	Homo sapiens	Inhibition	%	0.59
	8214661	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.77	CHEMBL4487	Homo sapiens	Inhibition	%	1.77
	8214813	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.2	CHEMBL4487	Homo sapiens	Inhibition	%	-2.2
	8215037	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.69	CHEMBL4487	Homo sapiens	Inhibition	%	1.69
	8215064	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.24	CHEMBL4487	Homo sapiens	Inhibition	%	1.24
	8215288	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.64	CHEMBL4487	Homo sapiens	Inhibition	%	1.64
	8215441	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.84	CHEMBL4487	Homo sapiens	Inhibition	%	1.84
	8215605	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.13	CHEMBL4487	Homo sapiens	Inhibition	%	2.13
	8215829	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.48	CHEMBL4487	Homo sapiens	Inhibition	%	2.48
	8215948	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.33	CHEMBL4487	Homo sapiens	Inhibition	%	1.33
	8216291	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.77	CHEMBL4487	Homo sapiens	Inhibition	%	0.77
	8216427	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.6	CHEMBL4487	Homo sapiens	Inhibition	%	2.6
	8216651	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.86	CHEMBL4487	Homo sapiens	Inhibition	%	2.86
	8216789	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.78	CHEMBL4487	Homo sapiens	Inhibition	%	0.78
	8217147	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.86	CHEMBL4487	Homo sapiens	Inhibition	%	3.86
	8217321	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.5	CHEMBL4487	Homo sapiens	Inhibition	%	0.5
	8217676	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	0.99	CHEMBL4487	Homo sapiens	Inhibition	%	0.99
	8218001	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.88	CHEMBL4487	Homo sapiens	Inhibition	%	-1.88
	8218116	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.66	CHEMBL4487	Homo sapiens	Inhibition	%	2.66
	8218467	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.01	CHEMBL4487	Homo sapiens	Inhibition	%	1.01
	8218610	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.45	CHEMBL4487	Homo sapiens	Inhibition	%	0.45
	8218834	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.2	CHEMBL4487	Homo sapiens	Inhibition	%	3.2
	8218965	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.45	CHEMBL4487	Homo sapiens	Inhibition	%	1.45
	8219349	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.57	CHEMBL4487	Homo sapiens	Inhibition	%	0.57
	8219599	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.75	CHEMBL4487	Homo sapiens	Inhibition	%	1.75
	8219760	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.73	CHEMBL4487	Homo sapiens	Inhibition	%	1.73
	8220153	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.69	CHEMBL4487	Homo sapiens	Inhibition	%	1.69
	8220282	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.54	CHEMBL4487	Homo sapiens	Inhibition	%	1.54
	8220506	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.55	CHEMBL4487	Homo sapiens	Inhibition	%	2.55
	8220620	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.46	CHEMBL4487	Homo sapiens	Inhibition	%	1.46
	8220982	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.05	CHEMBL4487	Homo sapiens	Inhibition	%	3.05
	8221118	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.09	CHEMBL4487	Homo sapiens	Inhibition	%	1.09
	8221475	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.31	CHEMBL4487	Homo sapiens	Inhibition	%	1.31
	8221640	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.36	CHEMBL4487	Homo sapiens	Inhibition	%	-0.36
	8221864	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.25	CHEMBL4487	Homo sapiens	Inhibition	%	0.25
	8221995	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.17	CHEMBL4487	Homo sapiens	Inhibition	%	2.17
	8222317	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.47	CHEMBL4487	Homo sapiens	Inhibition	%	2.47
	8222451	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.42	CHEMBL4487	Homo sapiens	Inhibition	%	2.42
	8222675	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.52	CHEMBL4487	Homo sapiens	Inhibition	%	2.52
	8222793	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.56	CHEMBL4487	Homo sapiens	Inhibition	%	1.56
	8223161	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.66	CHEMBL4487	Homo sapiens	Inhibition	%	3.66
	8223290	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.09	CHEMBL4487	Homo sapiens	Inhibition	%	2.09
	8223675	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.46	CHEMBL4487	Homo sapiens	Inhibition	%	0.46
	8223925	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.04	CHEMBL4487	Homo sapiens	Inhibition	%	2.04
	8224087	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.44	CHEMBL4487	Homo sapiens	Inhibition	%	1.44
	8224311	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.66	CHEMBL4487	Homo sapiens	Inhibition	%	1.66
	8224481	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.01	CHEMBL4487	Homo sapiens	Inhibition	%	2.01
	8224840	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.96	CHEMBL4487	Homo sapiens	Inhibition	%	1.96
	8224954	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.71	CHEMBL4487	Homo sapiens	Inhibition	%	0.71
	8225312	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.22	CHEMBL4487	Homo sapiens	Inhibition	%	3.22
	8225450	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.82	CHEMBL4487	Homo sapiens	Inhibition	%	0.82
	8225674	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.09	CHEMBL4487	Homo sapiens	Inhibition	%	-0.09
	8225809	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.49	CHEMBL4487	Homo sapiens	Inhibition	%	2.49
	8226191	CHEMBL1962219	GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.56	CHEMBL4487	Homo sapiens	Inhibition	%	1.56
	8226316	CHEMBL1962218	GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.6	CHEMBL4487	Homo sapiens	Inhibition	%	1.6
	10839435	CHEMBL2015420	Inhibition of PAK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	13.0	CHEMBL4487	Homo sapiens	INH	%	13.0
	10839618	CHEMBL2016309	Inhibition of PAK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	86.0	CHEMBL4487	Homo sapiens	Activity	%	86.0
	10839688	CHEMBL2015177	Inhibition of PAK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	57.0	CHEMBL4487	Homo sapiens	Activity	%	57.0
	10867537	CHEMBL2027427	Inhibition of PAK2 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	10878755	CHEMBL2025864	Inhibition of PAK2 at 1 uM relative to control	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023534	<	Inhibition	%	30.0	CHEMBL4487	Homo sapiens	INH	%	30.0
	10926122	CHEMBL2046210	Inhibition of human PAK2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	106.0	CHEMBL4487	Homo sapiens	Activity	%	106.0
	10926123	CHEMBL2046210	Inhibition of human PAK2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	104.0	CHEMBL4487	Homo sapiens	Activity	%	104.0
	10978451	CHEMBL2066256	Inhibition of human recombinant PAK2 expressed in Sf9 cells using ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL4487	Homo sapiens	Activity	%	80.0
	12047291	CHEMBL2157316	Inhibition of PAK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.6	CHEMBL4487	Homo sapiens	INH	%	2.6
	12074691	CHEMBL2161412	Inhibition of PAK2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	12145263	CHEMBL2183036	Inhibition of PAK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL4487	Homo sapiens	INH	%	25.0
	12145264	CHEMBL2183036	Inhibition of PAK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL4487	Homo sapiens	INH	%	25.0
	12166109	CHEMBL2211137	Binding affinity to PAK2 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL4487	Homo sapiens	Activity	%	50.0
	12170760	CHEMBL2209887	Inhibition of PAK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	116.0	CHEMBL4487	Homo sapiens	Activity	%	116.0
	12170891	CHEMBL2213210	Inhibition of PAK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	87.0	CHEMBL4487	Homo sapiens	Activity	%	87.0
	12172303	CHEMBL2215418	Inhibition of PAK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	12195595	CHEMBL2212374	Inhibition of human recombinant PAK2 expressed in Sf9 cells using Ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	103.7	CHEMBL4487	Homo sapiens	Activity	%	103.7
	12213527	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	125.0	CHEMBL4487	Homo sapiens	Residual Activity	%	125.0
	12213528	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12213529	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	116.0	CHEMBL4487	Homo sapiens	Residual Activity	%	116.0
	12213530	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	112.0	CHEMBL4487	Homo sapiens	Residual Activity	%	112.0
	12213531	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12213532	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	115.0	CHEMBL4487	Homo sapiens	Residual Activity	%	115.0
	12213533	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	124.0	CHEMBL4487	Homo sapiens	Residual Activity	%	124.0
	12213534	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	126.0	CHEMBL4487	Homo sapiens	Residual Activity	%	126.0
	12213535	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12213536	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12213537	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	82.0	CHEMBL4487	Homo sapiens	Residual Activity	%	82.0
	12213538	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12213539	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12213540	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12213541	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12213542	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	114.0	CHEMBL4487	Homo sapiens	Residual Activity	%	114.0
	12213543	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL4487	Homo sapiens	Residual Activity	%	109.0
	12213544	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12213545	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL4487	Homo sapiens	Residual Activity	%	96.0
	12213546	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12213547	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12213548	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12213549	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12213550	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	112.0	CHEMBL4487	Homo sapiens	Residual Activity	%	112.0
	12213551	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12213552	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12213553	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12213554	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12213555	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12213556	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12213557	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12213558	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	112.0	CHEMBL4487	Homo sapiens	Residual Activity	%	112.0
	12213559	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12213560	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12213561	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216398	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12216399	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12216400	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216401	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216402	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	113.0	CHEMBL4487	Homo sapiens	Residual Activity	%	113.0
	12216403	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	117.0	CHEMBL4487	Homo sapiens	Residual Activity	%	117.0
	12216404	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216405	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216406	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12216407	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216408	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216409	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216410	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	108.0	CHEMBL4487	Homo sapiens	Residual Activity	%	108.0
	12216411	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216412	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216413	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	94.0	CHEMBL4487	Homo sapiens	Residual Activity	%	94.0
	12216414	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216415	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	96.0	CHEMBL4487	Homo sapiens	Residual Activity	%	96.0
	12216416	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216417	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216418	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216419	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	115.0	CHEMBL4487	Homo sapiens	Residual Activity	%	115.0
	12216420	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216421	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12216422	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12216423	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216424	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	72.0	CHEMBL4487	Homo sapiens	Residual Activity	%	72.0
	12216425	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	88.0	CHEMBL4487	Homo sapiens	Residual Activity	%	88.0
	12216426	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216427	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	114.0	CHEMBL4487	Homo sapiens	Residual Activity	%	114.0
	12216428	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	96.0	CHEMBL4487	Homo sapiens	Residual Activity	%	96.0
	12216429	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	108.0	CHEMBL4487	Homo sapiens	Residual Activity	%	108.0
	12216430	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216431	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216432	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216433	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216434	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	116.0	CHEMBL4487	Homo sapiens	Residual Activity	%	116.0
	12216435	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	115.0	CHEMBL4487	Homo sapiens	Residual Activity	%	115.0
	12216436	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	113.0	CHEMBL4487	Homo sapiens	Residual Activity	%	113.0
	12216437	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216438	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216439	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216440	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12216441	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	115.0	CHEMBL4487	Homo sapiens	Residual Activity	%	115.0
	12216442	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	5.0	CHEMBL4487	Homo sapiens	Residual Activity	%	5.0
	12216443	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	109.0	CHEMBL4487	Homo sapiens	Residual Activity	%	109.0
	12216444	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	118.0	CHEMBL4487	Homo sapiens	Residual Activity	%	118.0
	12216445	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	122.0	CHEMBL4487	Homo sapiens	Residual Activity	%	122.0
	12216446	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216447	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216448	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216449	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216450	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12216451	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	113.0	CHEMBL4487	Homo sapiens	Residual Activity	%	113.0
	12216452	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216453	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12216454	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216455	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216456	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216457	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216458	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	109.0	CHEMBL4487	Homo sapiens	Residual Activity	%	109.0
	12216459	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216460	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216461	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12216462	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	94.0	CHEMBL4487	Homo sapiens	Residual Activity	%	94.0
	12216463	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216464	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	19.0	CHEMBL4487	Homo sapiens	Residual Activity	%	19.0
	12216465	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216466	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216467	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	43.0	CHEMBL4487	Homo sapiens	Residual Activity	%	43.0
	12216468	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216469	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216470	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216471	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216472	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216473	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216474	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216475	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	62.0	CHEMBL4487	Homo sapiens	Residual Activity	%	62.0
	12216476	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216477	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216478	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216479	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12216480	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216481	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216482	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	116.0	CHEMBL4487	Homo sapiens	Residual Activity	%	116.0
	12216483	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12216484	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216485	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	109.0	CHEMBL4487	Homo sapiens	Residual Activity	%	109.0
	12216486	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216487	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	80.0	CHEMBL4487	Homo sapiens	Residual Activity	%	80.0
	12216488	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216489	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216490	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216491	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	112.0	CHEMBL4487	Homo sapiens	Residual Activity	%	112.0
	12216492	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	47.0	CHEMBL4487	Homo sapiens	Residual Activity	%	47.0
	12216493	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216494	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216495	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	96.0	CHEMBL4487	Homo sapiens	Residual Activity	%	96.0
	12216496	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216497	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216498	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	113.0	CHEMBL4487	Homo sapiens	Residual Activity	%	113.0
	12216499	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12216500	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216501	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216502	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216503	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216504	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216505	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216506	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	118.0	CHEMBL4487	Homo sapiens	Residual Activity	%	118.0
	12216507	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216508	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	88.0	CHEMBL4487	Homo sapiens	Residual Activity	%	88.0
	12216509	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216510	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	105.0	CHEMBL4487	Homo sapiens	Residual Activity	%	105.0
	12216511	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216512	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216513	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216514	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216515	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216516	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12216517	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12216518	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216519	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12216520	CHEMBL2219357	Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216521	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216522	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	85.0	CHEMBL4487	Homo sapiens	Residual Activity	%	85.0
	12216523	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216524	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12216525	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216526	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216527	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216528	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216529	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12216530	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12216531	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	81.0	CHEMBL4487	Homo sapiens	Residual Activity	%	81.0
	12216532	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216533	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	84.0	CHEMBL4487	Homo sapiens	Residual Activity	%	84.0
	12216534	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	49.0	CHEMBL4487	Homo sapiens	Residual Activity	%	49.0
	12216535	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216536	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	108.0	CHEMBL4487	Homo sapiens	Residual Activity	%	108.0
	12216537	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	81.0	CHEMBL4487	Homo sapiens	Residual Activity	%	81.0
	12216538	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	81.0	CHEMBL4487	Homo sapiens	Residual Activity	%	81.0
	12216539	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12216540	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216541	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12216542	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	79.0	CHEMBL4487	Homo sapiens	Residual Activity	%	79.0
	12216543	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216544	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216545	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216546	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216547	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216548	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	80.0	CHEMBL4487	Homo sapiens	Residual Activity	%	80.0
	12216549	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12216550	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	67.0	CHEMBL4487	Homo sapiens	Residual Activity	%	67.0
	12216551	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	88.0	CHEMBL4487	Homo sapiens	Residual Activity	%	88.0
	12216552	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216553	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	85.0	CHEMBL4487	Homo sapiens	Residual Activity	%	85.0
	12216554	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12216555	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL4487	Homo sapiens	Residual Activity	%	88.0
	12216556	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	81.0	CHEMBL4487	Homo sapiens	Residual Activity	%	81.0
	12216557	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	77.0	CHEMBL4487	Homo sapiens	Residual Activity	%	77.0
	12216558	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12216559	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216560	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216561	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	120.0	CHEMBL4487	Homo sapiens	Residual Activity	%	120.0
	12216562	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216563	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12216564	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	37.0	CHEMBL4487	Homo sapiens	Residual Activity	%	37.0
	12216565	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216566	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	82.0	CHEMBL4487	Homo sapiens	Residual Activity	%	82.0
	12216567	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216568	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216569	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216570	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	94.0	CHEMBL4487	Homo sapiens	Residual Activity	%	94.0
	12216571	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	66.0	CHEMBL4487	Homo sapiens	Residual Activity	%	66.0
	12216572	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	61.0	CHEMBL4487	Homo sapiens	Residual Activity	%	61.0
	12216573	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	54.0	CHEMBL4487	Homo sapiens	Residual Activity	%	54.0
	12216574	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL4487	Homo sapiens	Residual Activity	%	82.0
	12216575	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	85.0	CHEMBL4487	Homo sapiens	Residual Activity	%	85.0
	12216576	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	111.0	CHEMBL4487	Homo sapiens	Residual Activity	%	111.0
	12216577	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12216578	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12216579	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216580	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	76.0	CHEMBL4487	Homo sapiens	Residual Activity	%	76.0
	12216581	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216582	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	50.0	CHEMBL4487	Homo sapiens	Residual Activity	%	50.0
	12216583	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216584	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216585	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL4487	Homo sapiens	Residual Activity	%	108.0
	12216586	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216587	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216588	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	80.0	CHEMBL4487	Homo sapiens	Residual Activity	%	80.0
	12216589	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216590	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216591	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	94.0	CHEMBL4487	Homo sapiens	Residual Activity	%	94.0
	12216592	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	58.0	CHEMBL4487	Homo sapiens	Residual Activity	%	58.0
	12216593	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	97.0	CHEMBL4487	Homo sapiens	Residual Activity	%	97.0
	12216594	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216595	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216596	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216597	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	76.0	CHEMBL4487	Homo sapiens	Residual Activity	%	76.0
	12216598	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	81.0	CHEMBL4487	Homo sapiens	Residual Activity	%	81.0
	12216599	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216600	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL4487	Homo sapiens	Residual Activity	%	-2.0
	12216601	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216602	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12216603	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216604	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12216605	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12216606	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216607	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216608	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216609	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12216610	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	54.0	CHEMBL4487	Homo sapiens	Residual Activity	%	54.0
	12216611	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	73.0	CHEMBL4487	Homo sapiens	Residual Activity	%	73.0
	12216612	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12216613	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	45.0	CHEMBL4487	Homo sapiens	Residual Activity	%	45.0
	12216614	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12216615	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	83.0	CHEMBL4487	Homo sapiens	Residual Activity	%	83.0
	12216616	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216617	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12216618	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216619	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL4487	Homo sapiens	Residual Activity	%	92.0
	12216620	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12216621	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12216622	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4487	Homo sapiens	Residual Activity	%	2.0
	12216623	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	102.0	CHEMBL4487	Homo sapiens	Residual Activity	%	102.0
	12216624	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12216625	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	30.0	CHEMBL4487	Homo sapiens	Residual Activity	%	30.0
	12216626	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12216627	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	92.0	CHEMBL4487	Homo sapiens	Residual Activity	%	92.0
	12216628	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	94.0	CHEMBL4487	Homo sapiens	Residual Activity	%	94.0
	12216629	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12216630	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	75.0	CHEMBL4487	Homo sapiens	Residual Activity	%	75.0
	12216631	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12218994	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12218995	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	37.0	CHEMBL4487	Homo sapiens	Residual Activity	%	37.0
	12218996	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12218997	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	82.0	CHEMBL4487	Homo sapiens	Residual Activity	%	82.0
	12218998	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	91.0	CHEMBL4487	Homo sapiens	Residual Activity	%	91.0
	12218999	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	71.0	CHEMBL4487	Homo sapiens	Residual Activity	%	71.0
	12219000	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12219001	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12219002	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL4487	Homo sapiens	Residual Activity	%	107.0
	12219003	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	68.0	CHEMBL4487	Homo sapiens	Residual Activity	%	68.0
	12219004	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	73.0	CHEMBL4487	Homo sapiens	Residual Activity	%	73.0
	12219005	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219006	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	92.0	CHEMBL4487	Homo sapiens	Residual Activity	%	92.0
	12219007	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	78.0	CHEMBL4487	Homo sapiens	Residual Activity	%	78.0
	12219008	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12219009	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	79.0	CHEMBL4487	Homo sapiens	Residual Activity	%	79.0
	12219010	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	106.0	CHEMBL4487	Homo sapiens	Residual Activity	%	106.0
	12219011	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12219012	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	7.0	CHEMBL4487	Homo sapiens	Residual Activity	%	7.0
	12219013	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	87.0	CHEMBL4487	Homo sapiens	Residual Activity	%	87.0
	12219014	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219015	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12219016	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219017	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	70.0	CHEMBL4487	Homo sapiens	Residual Activity	%	70.0
	12219018	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	86.0	CHEMBL4487	Homo sapiens	Residual Activity	%	86.0
	12219019	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12219020	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	42.0	CHEMBL4487	Homo sapiens	Residual Activity	%	42.0
	12219021	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	88.0	CHEMBL4487	Homo sapiens	Residual Activity	%	88.0
	12219022	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219023	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219024	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	93.0	CHEMBL4487	Homo sapiens	Residual Activity	%	93.0
	12219025	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12219026	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	103.0	CHEMBL4487	Homo sapiens	Residual Activity	%	103.0
	12219027	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL4487	Homo sapiens	Residual Activity	%	98.0
	12219028	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	69.0	CHEMBL4487	Homo sapiens	Residual Activity	%	69.0
	12219029	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	100.0	CHEMBL4487	Homo sapiens	Residual Activity	%	100.0
	12219030	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	85.0	CHEMBL4487	Homo sapiens	Residual Activity	%	85.0
	12219031	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	109.0	CHEMBL4487	Homo sapiens	Residual Activity	%	109.0
	12219032	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL4487	Homo sapiens	Residual Activity	%	110.0
	12219033	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	101.0	CHEMBL4487	Homo sapiens	Residual Activity	%	101.0
	12219034	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12219035	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	95.0	CHEMBL4487	Homo sapiens	Residual Activity	%	95.0
	12219036	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL4487	Homo sapiens	Residual Activity	%	99.0
	12219037	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL4487	Homo sapiens	Residual Activity	%	104.0
	12219038	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	89.0	CHEMBL4487	Homo sapiens	Residual Activity	%	89.0
	12219039	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	85.0	CHEMBL4487	Homo sapiens	Residual Activity	%	85.0
	12219040	CHEMBL2219358	Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	90.0	CHEMBL4487	Homo sapiens	Residual Activity	%	90.0
	12647895	CHEMBL2329068	Inhibition of PAK2 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	12647896	CHEMBL2329068	Inhibition of PAK2 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	29.0	CHEMBL4487	Homo sapiens	INH	%	29.0
	12647897	CHEMBL2329068	Inhibition of PAK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	7.0	CHEMBL4487	Homo sapiens	INH	%	7.0
	12647898	CHEMBL2329068	Inhibition of PAK2 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	17.0	CHEMBL4487	Homo sapiens	INH	%	17.0
	12649582	CHEMBL2329526	Inhibition of PAK2 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	75.0	CHEMBL4487	Homo sapiens	INH	%	75.0
	12649583	CHEMBL2329526	Inhibition of PAK2 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	45.0	CHEMBL4487	Homo sapiens	INH	%	45.0
	12649584	CHEMBL2329526	Inhibition of PAK2 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	62.0	CHEMBL4487	Homo sapiens	INH	%	62.0
	12672945	CHEMBL2339289	Inhibition of recombinant PAK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	38.0	CHEMBL4487	Homo sapiens	Activity	%	38.0
	12672946	CHEMBL2339289	Inhibition of recombinant PAK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	45.0	CHEMBL4487	Homo sapiens	Activity	%	45.0
	12675464	CHEMBL2344386	Inhibition of PAK2 (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	12727707	CHEMBL2350885	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	97.0	CHEMBL4487	Homo sapiens	Activity	%	97.0
	12728995	CHEMBL2350172	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL4487	Homo sapiens	Activity	%	98.0
	12729872	CHEMBL2349776	Inhibition of PAK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL4487	Homo sapiens	Activity	%	94.0
	12730138	CHEMBL2350885	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL4487	Homo sapiens	Activity	%	98.0
	13281323	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
	13281324	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	26.0	CHEMBL4487	Homo sapiens	INH	%	26.0
	13281325	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376153	=	Inhibition	%	-29.0	CHEMBL4487	Homo sapiens	INH	%	-29.0
	13281326	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	7.0	CHEMBL4487	Homo sapiens	INH	%	7.0
	13281327	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-7.0	CHEMBL4487	Homo sapiens	INH	%	-7.0
	13281328	CHEMBL2378212	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	29.0	CHEMBL4487	Homo sapiens	INH	%	29.0
	13327514	CHEMBL2388904	Inhibition of PAK2-mediated MEK1 phosphorylation at Ser298 in human EBC1 cells after 2 hrs by HTRF assay	B	COCCN(Cc1cc(F)cc2[nH]ncc12)c1nccc(Nc2cc(C3CC3)[nH]n2)n1		CHEMBL2386715	=	IC50	nM	64.1	CHEMBL4487	Homo sapiens	IC50	uM	0.0641
	13327515	CHEMBL2388904	Inhibition of PAK2-mediated MEK1 phosphorylation at Ser298 in human EBC1 cells after 2 hrs by HTRF assay	B	CC(CO)N(Cc1cc(F)cc2[nH]ncc12)c1nccc(Nc2cc(C3CC3)[nH]n2)n1		CHEMBL2386717	=	IC50	nM	70.8	CHEMBL4487	Homo sapiens	IC50	uM	0.0708
	13327516	CHEMBL2388904	Inhibition of PAK2-mediated MEK1 phosphorylation at Ser298 in human EBC1 cells after 2 hrs by HTRF assay	B	C[C@H](Nc1nccc(Nc2cc(C3CCC3)[nH]n2)n1)c1ccc2[nH]ccc2c1		CHEMBL2386716	=	IC50	nM	133.0	CHEMBL4487	Homo sapiens	IC50	uM	0.133
	13327517	CHEMBL2388904	Inhibition of PAK2-mediated MEK1 phosphorylation at Ser298 in human EBC1 cells after 2 hrs by HTRF assay	B	C[C@H](Nc1nccc(Nc2cc(C3CC3(F)F)[nH]n2)n1)c1ccc2[nH]cnc2c1		CHEMBL2386718	=	IC50	nM	244.0	CHEMBL4487	Homo sapiens	IC50	uM	0.244
	13365773	CHEMBL2406327	Inhibition of PAK2 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	13374414	CHEMBL2406547	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL4487	Homo sapiens	INH	%	2.0
	13419577	CHEMBL2423814	Inhibition of PAK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	13.0	CHEMBL4487	Homo sapiens	INH	%	13.0
	13419578	CHEMBL2423814	Inhibition of PAK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	19.0	CHEMBL4487	Homo sapiens	INH	%	19.0
	13419579	CHEMBL2423814	Inhibition of PAK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	20.0	CHEMBL4487	Homo sapiens	INH	%	20.0
	13439790	CHEMBL2429143	Competitive binding affinity to PAK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	13442620	CHEMBL2429143	Competitive binding affinity to PAK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	82.0	CHEMBL4487	Homo sapiens	INH	%	82.0
	13445623	CHEMBL2429143	Competitive binding affinity to PAK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	13451610	CHEMBL2429143	Competitive binding affinity to PAK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	13872074	CHEMBL3101259	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	124.0	CHEMBL4487	Homo sapiens	Activity	%	124.0
	13941113	CHEMBL3129190	Inhibition of PAK2 (unknown origin)	B	COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1		CHEMBL3128042	=	IC50	nM	970.0	CHEMBL4487	Homo sapiens	IC50	uM	0.97
	13953310	CHEMBL3130707	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	94.0	CHEMBL4487	Homo sapiens	Activity	%	94.0
	13953323	CHEMBL3130707	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	92.0	CHEMBL4487	Homo sapiens	Activity	%	92.0
	13953341	CHEMBL3130707	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	90.0	CHEMBL4487	Homo sapiens	Activity	%	90.0
	13965696	CHEMBL3135781	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	26.0	CHEMBL4487	Homo sapiens	INH	%	26.0
	13966074	CHEMBL3137061	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	13.5	CHEMBL4487	Homo sapiens	INH	%	13.5
Not Active	13973387	CHEMBL3134659	Inhibition of PAK2 (unknown origin) using tetra(LRRWSLG) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	13973976	CHEMBL3135749	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	13974067	CHEMBL3134727	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	1.5	CHEMBL4487	Homo sapiens	INH	%	1.5
	13974158	CHEMBL3136495	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	13974249	CHEMBL3135630	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	55.5	CHEMBL4487	Homo sapiens	INH	%	55.5
	13974987	CHEMBL3135153	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	67.5	CHEMBL4487	Homo sapiens	INH	%	67.5
	13975078	CHEMBL3136723	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	6.0	CHEMBL4487	Homo sapiens	INH	%	6.0
	13975169	CHEMBL3134952	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	1.5	CHEMBL4487	Homo sapiens	INH	%	1.5
	13975260	CHEMBL3137143	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	3.5	CHEMBL4487	Homo sapiens	INH	%	3.5
	13975903	CHEMBL3136270	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	24.5	CHEMBL4487	Homo sapiens	INH	%	24.5
	13975996	CHEMBL3136305	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	11.0	CHEMBL4487	Homo sapiens	INH	%	11.0
	13976087	CHEMBL3136187	Inhibition of human truncated PAK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	57.5	CHEMBL4487	Homo sapiens	INH	%	57.5
	14582574	CHEMBL3241638	Inhibition of human PAK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	113.5	CHEMBL4487	Homo sapiens	Activity	%	113.5
	14593779	CHEMBL3242868	Inhibition of human PAK2	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	14664269	CHEMBL3271249	Inhibition of PAK2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	99.0	CHEMBL4487	Homo sapiens	INH	%	99.0
	14664270	CHEMBL3271249	Inhibition of PAK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL4487	Homo sapiens	INH	%	100.0
	14664271	CHEMBL3271249	Inhibition of PAK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	89.0	CHEMBL4487	Homo sapiens	INH	%	89.0
	14992849	CHEMBL3372240	Inhibition of recombinant PAK2 (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	100000.0	CHEMBL4487	Homo sapiens	IC50	uM	100.0
	15018656	CHEMBL3361548	Inhibition of PAK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	7.8	CHEMBL4487	Homo sapiens	INH	%	7.8
	15072412	CHEMBL3388081	Inhibition of PAK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	109.0	CHEMBL4487	Homo sapiens	Activity	%	109.0
	15091077	CHEMBL3382225	Inhibition of human recombinant PAK2 expressed Sf9 cells using Ulight-RRRSLLE substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	76.0	CHEMBL4487	Homo sapiens	Activity	%	76.0
	15109401	CHEMBL3373411	Inhibition of PAK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	25.0	CHEMBL4487	Homo sapiens	Activity	%	25.0
	15150108	CHEMBL3396176	Inhibition of PAK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	15150109	CHEMBL3396176	Inhibition of PAK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	15150110	CHEMBL3396176	Inhibition of PAK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	15150111	CHEMBL3396176	Inhibition of PAK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	15150112	CHEMBL3396176	Inhibition of PAK2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	15251817	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	70.0	CHEMBL4487	Homo sapiens	Activity	%	70.0
	15251980	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	50.0	CHEMBL4487	Homo sapiens	Activity	%	50.0
	15252082	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	95.0	CHEMBL4487	Homo sapiens	Activity	%	95.0
	15252727	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	112.0	CHEMBL4487	Homo sapiens	Activity	%	112.0
	15252829	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	87.0	CHEMBL4487	Homo sapiens	Activity	%	87.0
	15253503	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	96.0	CHEMBL4487	Homo sapiens	Activity	%	96.0
	15253605	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	102.0	CHEMBL4487	Homo sapiens	Activity	%	102.0
	15253707	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	102.0	CHEMBL4487	Homo sapiens	Activity	%	102.0
	15254373	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	85.0	CHEMBL4487	Homo sapiens	Activity	%	85.0
	15254475	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	89.0	CHEMBL4487	Homo sapiens	Activity	%	89.0
	15254577	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	103.0	CHEMBL4487	Homo sapiens	Activity	%	103.0
	15255267	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	90.0	CHEMBL4487	Homo sapiens	Activity	%	90.0
	15255370	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	89.0	CHEMBL4487	Homo sapiens	Activity	%	89.0
	15255472	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	91.0	CHEMBL4487	Homo sapiens	Activity	%	91.0
	15256204	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	89.0	CHEMBL4487	Homo sapiens	Activity	%	89.0
	15256306	CHEMBL3428403	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	68.0	CHEMBL4487	Homo sapiens	Activity	%	68.0
	15673255	CHEMBL3603409	Inhibition of human PAK2 at 1 uM	B	O=c1cc(-c2ccc3nc(NCC4CCOCC4)sc3c2)ccn1CC1CC1		CHEMBL3600781	=	Inhibition	%	49.0	CHEMBL4487	Homo sapiens	INH	%	49.0
	15673256	CHEMBL3603409	Inhibition of human PAK2 at 1 uM	B	O=c1cc(-c2ccc3nc(NCC4CCS(=O)(=O)CC4)sc3c2)ccn1CC1CC1		CHEMBL3600784	=	Inhibition	%	53.0	CHEMBL4487	Homo sapiens	INH	%	53.0
	15690692	CHEMBL3611421	Inhibition of PAK2 (unknown origin)	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	IC50	nM	190.0	CHEMBL4487	Homo sapiens	IC50	nM	190.0
Active	15690695	CHEMBL3610960	Inhibition of PAK2 in human SU8686 cells assessed as MEK1 phosphorylation at Ser289 at 0.21 uM after 30 mins by Western blot analysis in presence of PAK2 shRNA	B	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		CHEMBL3609372		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Active	15690697	CHEMBL3610958	Inhibition of PAK2 in human SU8686 cells assessed as MEK1 phosphorylation at Ser289 at 6 to 20 uM after 30 mins by Western blot analysis	B	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		CHEMBL3609372		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	15690699	CHEMBL3610956	Inhibition of PAK2 in human SU8686 cells assessed as MEK1 phosphorylation at Ser289 up to 2 to 6 uM after 30 mins by Western blot analysis	B	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		CHEMBL3609372		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Active	15690701	CHEMBL3610954	Inhibition of PAK2 autophosphorylation at Ser141 in human SU8686 cells at 0.009 to 20 uM after 30 mins by Western blot analysis	B	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		CHEMBL3609372		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	15690725	CHEMBL3610938	Binding affinity to PAK2 (unknown origin) expressed in HEK293 cells after 1 hr by qPCR analysis	B	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		CHEMBL3609372	=	Kd	nM	400.0	CHEMBL4487	Homo sapiens	Kd	nM	400.0
	15690726	CHEMBL3610938	Binding affinity to PAK2 (unknown origin) expressed in HEK293 cells after 1 hr by qPCR analysis	B	CCN1c2ccc(F)cc2N=C(N[C@H]2CCN(C(=O)NC(C)(C)C)C2)c2cc(Cl)ccc21		CHEMBL3609371	=	Kd	nM	1100.0	CHEMBL4487	Homo sapiens	Kd	nM	1100.0
	15690727	CHEMBL3610938	Binding affinity to PAK2 (unknown origin) expressed in HEK293 cells after 1 hr by qPCR analysis	B	CCN1c2ccc(F)cc2N=C(N[C@H]2CCN(C(=O)OC(C)(C)C)C2)c2cc(Cl)ccc21		CHEMBL3609370	>	Kd	nM	40000.0	CHEMBL4487	Homo sapiens	Kd	nM	40000.0
	15690728	CHEMBL3610938	Binding affinity to PAK2 (unknown origin) expressed in HEK293 cells after 1 hr by qPCR analysis	B	CCN1c2ccc(F)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21		CHEMBL3609330	>	Kd	nM	40000.0	CHEMBL4487	Homo sapiens	Kd	nM	40000.0
	15690750	CHEMBL3611546	Inhibition of full length PAK2 (unknown origin) by Z'-LYTE assay	B	CCn1c(=O)c(-c2ccc(Cl)cc2Cl)cc2cnc(Nc3ccc(N4CCNCC4)c(F)c3)nc21		CHEMBL3609326	=	IC50	nM	39.5	CHEMBL4487	Homo sapiens	IC50	nM	39.5
	15690754	CHEMBL3611427	Inhibition of recombinant human PAK2 by Z'-LYTE assay	B	CCn1c(=O)c(-c2ccc(-c3cncs3)cc2Cl)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21		CHEMBL3609327	=	IC50	nM	12.8	CHEMBL4487	Homo sapiens	IC50	nM	12.8
	15735987	CHEMBL3624361	Inhibition of human recombinant PAK2	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	15755909	CHEMBL3630852	Inhibition of PAK2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	82.0	CHEMBL4487	Homo sapiens	Activity	%	82.0
	15756875	CHEMBL3630908	Inhibition of PAK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	9.28	CHEMBL4487	Homo sapiens	INH	%	9.28
	15757848	CHEMBL3630908	Inhibition of PAK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	15.8	CHEMBL4487	Homo sapiens	INH	%	15.8
	15758827	CHEMBL3630908	Inhibition of PAK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	6.88	CHEMBL4487	Homo sapiens	INH	%	6.88
	16376469	CHEMBL3734493	Inhibition of recombinant human PAK2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
	16422029	CHEMBL3750417	Inhibition of PAK2 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	16431943	CHEMBL3748036	Inhibition of human PAK2 using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	uM	10.0
	16451546	CHEMBL3760669	Inhibition of PAK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	0.3	CHEMBL4487	Homo sapiens	INH	%	0.3
	16483321	CHEMBL3772532	Inhibition of human recombinant PAK2	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	=	IC50	nM	11.0	CHEMBL4487	Homo sapiens	IC50	nM	11.0
	16483336	CHEMBL3772909	Inhibition of human recombinant PAK2 at 0.1 uM	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	>	Inhibition	%	70.0	CHEMBL4487	Homo sapiens	INH	%	70.0
	16486368	CHEMBL3771602	Inhibition of human recombinant PAK2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	95.0	CHEMBL4487	Homo sapiens	Activity	%	95.0
	16495154	CHEMBL3777733	Inhibition of N-terminal His6-tagged recombinant human PAK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-16.0	CHEMBL4487	Homo sapiens	Activity	%	-16.0
	16496073	CHEMBL3777733	Inhibition of N-terminal His6-tagged recombinant human PAK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	1.0	CHEMBL4487	Homo sapiens	Activity	%	1.0
	16508260	CHEMBL3777733	Inhibition of N-terminal His6-tagged recombinant human PAK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-5.0	CHEMBL4487	Homo sapiens	Activity	%	-5.0
Not Active	16514153	CHEMBL3782374	Inhibition of partial length human PAK2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	16559736	CHEMBL3794943	Inhibition of full length human N-terminal GST-tagged PAK2 (1 to 524 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	0.8	CHEMBL4487	Homo sapiens	INH	%	0.8
	16559737	CHEMBL3794943	Inhibition of full length human N-terminal GST-tagged PAK2 (1 to 524 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-1.6	CHEMBL4487	Homo sapiens	INH	%	-1.6
	16559738	CHEMBL3794943	Inhibition of full length human N-terminal GST-tagged PAK2 (1 to 524 residues) expressed in baculovirus expression system using fluorescence labelled DAPK1tide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	0.6	CHEMBL4487	Homo sapiens	INH	%	0.6
	16578360	CHEMBL3804619	Inhibition of partial length wild type human PAK2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	94.0	CHEMBL4487	Homo sapiens	Activity	%	94.0
	16593510	CHEMBL3813183	Inhibition of GST-tagged full length human recombinant PAK2 expressed in baculovirus at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4487	Homo sapiens	INH	%	40.0
	16594861	CHEMBL3812876	Inhibition of human PAK2 (151 to 525 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	57.0	CHEMBL4487	Homo sapiens	Activity	%	57.0
	16612625	CHEMBL3815495	Inhibition of human PAK2 (1 to 524 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	1.0	CHEMBL4487	Homo sapiens	Activity	%	1.0
	16614575	CHEMBL3817606	Inhibition of human PAK2 at 1 uM using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
	16618141	CHEMBL3817344	Inhibition of full length recombinant human GST-tagged PAK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	16619469	CHEMBL3820374	Inhibition of recombinant human full length GST-tagged PAK2 at 0.1 uM relative to control	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	>	Inhibition	%	75.0	CHEMBL4487	Homo sapiens	INH	%	75.0
	16619496	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	=	Ki	nM	11.0	CHEMBL4487	Homo sapiens	Ki	nM	11.0
	16619534	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CCn1c(=O)c(-c2ccc(-n3cccc(C)c3=O)cc2Cl)cc2cnc(NC3COC3)nc21		CHEMBL3817984	=	Ki	nM	21.0	CHEMBL4487	Homo sapiens	Ki	nM	21.0
	16619588	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CNc1ncc2cc(-c3ccc(-n4cccc(C)c4=O)cc3Cl)c(=O)n(CCC3(F)CN(C)C3)c2n1		CHEMBL3818265	=	Ki	nM	2.0	CHEMBL4487	Homo sapiens	Ki	nM	2.0
	16619602	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CCn1c(=O)c(-c2ccc(-c3cncc(C)n3)cc2Cl)cc2cnc(NCCC3CCN(C)CC3)nc21		CHEMBL3770186	=	Ki	nM	48.0	CHEMBL4487	Homo sapiens	Ki	nM	48.0
	16619619	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CCc1cccn(-c2ccc(-c3cc4cnc(NC)nc4n(C[C@H]4CNCCO4)c3=O)c(Cl)c2)c1=O		CHEMBL3819118	=	Ki	nM	9.5	CHEMBL4487	Homo sapiens	Ki	nM	9.5
	16619627	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	Cc1nccn(-c2ccc(-c3cc4cnc(NC5COC5)nc4n(CC4CCNCC4(F)F)c3=O)c(Cl)c2)c1=O		CHEMBL3818479	=	Ki	nM	4.6	CHEMBL4487	Homo sapiens	Ki	nM	4.6
	16619634	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CNc1ncc2cc(-c3ccc(-n4cncc(C)c4=O)cc3Cl)c(=O)n(CCOC)c2n1		CHEMBL3819447	=	Ki	nM	39.0	CHEMBL4487	Homo sapiens	Ki	nM	39.0
	16619642	CHEMBL3820373	Inhibition of recombinant human full length GST-tagged PAK2 expressed in Baculovirus at 1 uM relative to control	B	CNc1ncc2cc(-c3ccc(-n4cncc(C)c4=O)cc3Cl)c(=O)n(CCOC)c2n1		CHEMBL3819447	>	Inhibition	%	75.0	CHEMBL4487	Homo sapiens	INH	%	75.0
	16619647	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	Cc1cncc(-c2ccc(-c3cc4cncnc4n(C[C@H]4CC[C@H](N)CC4)c3=O)c(Cl)c2)n1		CHEMBL3819371	=	Ki	nM	940.0	CHEMBL4487	Homo sapiens	Ki	nM	940.0
	16619654	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CNc1ncc2cc(-c3ccc(-n4cccc(C)c4=O)cc3C3CC3)c(=O)n(C[C@@H]3CNCCO3)c2n1		CHEMBL3819633	=	Ki	nM	3670.0	CHEMBL4487	Homo sapiens	Ki	nM	3670.0
	16619661	CHEMBL3820957	Inhibition of human recombinant PAK2 assessed as phosphorylation of coumarin labeled FRET peptide substrate at Ser/Thr19 preincubated for 10 mins followed by ATP addition measured after 60 mins by Z'-LYTE assay	B	CNc1ncc2cc(-c3ccc(-n4ccc(C)cc4=O)cc3Cl)c(=O)n(C[C@H]3CNCCO3)c2n1		CHEMBL3818261	=	Ki	nM	2300.0	CHEMBL4487	Homo sapiens	Ki	nM	2300.0
	16619705	CHEMBL3820373	Inhibition of recombinant human full length GST-tagged PAK2 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL4487	Homo sapiens	INH	%	75.0
	16654214	CHEMBL3829308	Inhibition of human PAK2 assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	88.0	CHEMBL4487	Homo sapiens	Activity	%	88.0
	16781480	CHEMBL3865569	Binding affinity to human PAK2 (P151 to R525 residues) expressed in bacterial expression system by KINOMEscan assay	A	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	Kd	nM	0.32	CHEMBL4487	Homo sapiens	Kd	nM	0.32
	16781504	CHEMBL3865548	Inhibition of N-terminal 6His-tagged recombinant human PAK2 (3-end residues) expressed in Escherichia coli	A	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	IC50	nM	6.0	CHEMBL4487	Homo sapiens	IC50	nM	6.0
	16781513	CHEMBL3865539	Inhibition of N-terminal 6His-tagged recombinant human PAK2 (3-end residues) expressed in expressed in Escherichia coli at 100 nM	A	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	Inhibition	%	98.0	CHEMBL4487	Homo sapiens	INH	%	98.0
412039	17776754	CHEMBL3888682	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	nM	10000.0
Inactive	17923572	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923573	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923574	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923575	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923576	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923577	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923578	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923579	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923580	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923581	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923582	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923583	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923584	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923585	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923586	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923587	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923588	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923589	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923590	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923591	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923592	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923593	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923594	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923595	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923596	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923597	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923598	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923599	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923600	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923601	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923602	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923603	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923604	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923605	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923606	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923607	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923608	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923609	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923610	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923611	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923612	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923613	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923614	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923615	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923616	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923617	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923618	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923619	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923620	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923621	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923622	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923623	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923624	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923625	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923626	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923627	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923628	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923629	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923630	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923631	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923632	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923633	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923634	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923635	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923636	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923637	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923638	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923639	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923640	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923641	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923642	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923643	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923644	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923645	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923646	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923647	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923648	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923649	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923650	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923651	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923652	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923653	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923654	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923655	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923656	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923657	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923658	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923659	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923660	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923661	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923662	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923663	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923664	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923665	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923666	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923667	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923668	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923669	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923670	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923671	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923672	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923673	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923674	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923675	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923676	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923677	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923678	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923679	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923680	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923681	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923682	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923683	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923684	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923685	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923686	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923687	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923688	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923689	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923690	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923691	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Active	17923692	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	4.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	4.0
Inactive	17923693	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923694	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923695	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923696	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923697	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923698	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923699	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923700	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923701	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923702	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923703	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923704	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923705	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923706	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923707	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923708	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923709	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923710	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923711	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923712	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923713	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923714	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923715	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923716	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923717	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923718	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923719	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923720	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923721	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923722	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923723	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923724	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923725	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923726	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923727	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923728	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923729	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923730	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923731	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923732	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923733	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923734	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923735	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923736	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923737	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923738	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923739	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923740	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923741	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923742	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923743	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923744	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923745	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923746	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923747	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923748	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923749	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923750	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923751	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923752	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923753	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923754	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923755	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923756	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923757	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923758	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923759	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923760	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923761	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923762	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923763	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923764	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923765	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923766	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923767	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923768	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923769	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923770	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923771	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923772	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923773	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923774	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923775	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923776	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923777	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923778	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923779	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923780	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923781	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923782	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923783	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923784	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923785	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17923786	CHEMBL3991812	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4487	Homo sapiens	Kd apparent	nM	30000.0
	18052925	CHEMBL4011937	Inhibition of PAK2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-17.3	CHEMBL4487	Homo sapiens	INH	%	-17.3
	18114207	CHEMBL4025287	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	81.0	CHEMBL4487	Homo sapiens	Activity	%	81.0
	18203811	CHEMBL4044098	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	18232105	CHEMBL4050397	Inhibition of human PAK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	97.0	CHEMBL4487	Homo sapiens	Activity	%	97.0
	18253437	CHEMBL4055002	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	76.0	CHEMBL4487	Homo sapiens	Activity	%	76.0
	18253438	CHEMBL4055002	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	77.0	CHEMBL4487	Homo sapiens	Activity	%	77.0
	18265856	CHEMBL4057306	Inhibition of PAK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-2.7	CHEMBL4487	Homo sapiens	INH	%	-2.7
	18266114	CHEMBL4057564	Inhibition of PAK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL4487	Homo sapiens	INH	%	-0.3
	18266200	CHEMBL4057650	Inhibition of PAK2 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-5.3	CHEMBL4487	Homo sapiens	INH	%	-5.3
	18275181	CHEMBL4118439	Inhibition of PAK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IGQGASGTVFTATDVALGQEVAIKQINLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-8.6	CHEMBL4487	Homo sapiens	INH	%	-8.6
	18275182	CHEMBL4118439	Inhibition of PAK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IGQGASGTVFTATDVALGQEVAIKQINLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	18275183	CHEMBL4118439	Inhibition of PAK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IGQGASGTVFTATDVALGQEVAIKQINLQK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-3.9	CHEMBL4487	Homo sapiens	INH	%	-3.9
	18282722	CHEMBL4120307	Inhibition of PAK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-2.7	CHEMBL4487	Homo sapiens	INH	%	-2.7
	18282949	CHEMBL4120534	Inhibition of PAK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-3.0	CHEMBL4487	Homo sapiens	INH	%	-3.0
	18283173	CHEMBL4120758	Inhibition of PAK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	12.0	CHEMBL4487	Homo sapiens	INH	%	12.0
	18379935	CHEMBL4145836	Inhibition of PAK2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	1.45	CHEMBL4487	Homo sapiens	INH	%	1.45
	18379987	CHEMBL4145888	Inhibition of PAK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.59	CHEMBL4487	Homo sapiens	IC50	nM	2.59
	18434135	CHEMBL4156117	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	18434209	CHEMBL4156117	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	18434269	CHEMBL4156117	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	6.0	CHEMBL4487	Homo sapiens	INH	%	6.0
	18434341	CHEMBL4156117	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	5.0	CHEMBL4487	Homo sapiens	INH	%	5.0
	18440353	CHEMBL4157177	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	85.0	CHEMBL4487	Homo sapiens	Activity	%	85.0
	18449885	CHEMBL4178119	Inhibition of human PAK2 T402E mutant (1 to 524 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	103.0	CHEMBL4487	Homo sapiens	Activity	%	103.0
	18463774	CHEMBL4181190	Inhibition of recombinant human N-terminal/C-terminal His6-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	8.0	CHEMBL4487	Homo sapiens	INH	%	8.0
	18484309	CHEMBL4185956	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	86.0	CHEMBL4487	Homo sapiens	Activity	%	86.0
	18484793	CHEMBL4185956	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL4487	Homo sapiens	Activity	%	99.0
	18489542	CHEMBL4187283	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	66.0	CHEMBL4487	Homo sapiens	Activity	%	66.0
	18507972	CHEMBL4191092	Inhibition of recombinant human PAK2 (3 to end residues) at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	1.0	CHEMBL4487	Homo sapiens	INH	%	1.0
	18653467	CHEMBL4230170	Inhibition of PAK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL4487	Homo sapiens	INH	%	1.0
	18653468	CHEMBL4230170	Inhibition of PAK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL4487	Homo sapiens	INH	%	-2.0
	18655379	CHEMBL4230856	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	82.0	CHEMBL4487	Homo sapiens	Activity	%	82.0
	18663938	CHEMBL4232922	Inhibition of partial length human PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	18664035	CHEMBL4233019	Binding affinity to partial length human PAK2 (P151 to R525 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4487	Homo sapiens	Kd	uM	5.0
	18665435	CHEMBL4233373	Inhibition of PAK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4487	Homo sapiens	IC50	nM	1000.0
	18674807	CHEMBL4235404	Inhibition of PAK2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL4487	Homo sapiens	Ki	nM	2000.0
	18674808	CHEMBL4235404	Inhibition of PAK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4487	Homo sapiens	Ki	nM	2000.0
	18674809	CHEMBL4235404	Inhibition of PAK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL4487	Homo sapiens	Ki	nM	10000.0
	18694012	CHEMBL4253465	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	2.0	CHEMBL4487	Homo sapiens	INH	%	2.0
	18694094	CHEMBL4253547	Inhibition of recombinant human full length GST-tagged PAK2 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	10.0	CHEMBL4487	Homo sapiens	INH	%	10.0
	18751180	CHEMBL4263889	Inhibition of PAK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4487	Homo sapiens	INH	%	3.0
	18752108	CHEMBL4264445	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	85.0	CHEMBL4487	Homo sapiens	Activity	%	85.0
	18761548	CHEMBL4266599	Inhibition of recombinant human N-terminal His6/T7-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-1.0	CHEMBL4487	Homo sapiens	INH	%	-1.0
	18761819	CHEMBL4266599	Inhibition of recombinant human N-terminal His6/T7-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	11.0	CHEMBL4487	Homo sapiens	INH	%	11.0
	18761982	CHEMBL4266599	Inhibition of recombinant human N-terminal His6/T7-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-3.0	CHEMBL4487	Homo sapiens	INH	%	-3.0
	18765627	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	4.7	CHEMBL4487	Homo sapiens	INH	%	4.7
	18765628	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	13.4	CHEMBL4487	Homo sapiens	INH	%	13.4
	18765629	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	16.9	CHEMBL4487	Homo sapiens	INH	%	16.9
	18765630	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	15.7	CHEMBL4487	Homo sapiens	INH	%	15.7
	18765631	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	18.9	CHEMBL4487	Homo sapiens	INH	%	18.9
	18765632	CHEMBL4267283	Inhibition of human N-terminal GST-tagged full length PAK2 (1 to 524 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	9.4	CHEMBL4487	Homo sapiens	INH	%	9.4
Not Active	18847289	CHEMBL4304931	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	18848119	CHEMBL4305115	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1 uM by Kinomescan assay relative to control	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	=	Activity	%	0.1	CHEMBL4487	Homo sapiens	Activity	%	0.1
	18848127	CHEMBL4305123	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system after 1 hr by Z-LYTE assay	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	>	IC50	nM	10000.0	CHEMBL4487	Homo sapiens	IC50	nM	10000.0
	18858109	CHEMBL4307955	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4487	Homo sapiens	Activity	%	100.0
	18938175	CHEMBL4327814	Inhibition of human PAK2 assessed as residual activity at 1 uM using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	105.39	CHEMBL4487	Homo sapiens	Activity	%	105.39
	18938176	CHEMBL4327814	Inhibition of human PAK2 assessed as residual activity at 1 uM using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	105.62	CHEMBL4487	Homo sapiens	Activity	%	105.62
	18938659	CHEMBL4328178	Inhibition of human PAK2 assessed as residual activity at 100 uM using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4487	Homo sapiens	Activity	%	65.0
	18939043	CHEMBL4328542	Inhibition of human PAK2 using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.46	CHEMBL4487	Homo sapiens	IC50	10'-9M	3.46
	18958651	CHEMBL4333540	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	75.0	CHEMBL4487	Homo sapiens	Activity	%	75.0
	19021598	CHEMBL4347821	Inhibition of recombinant human PAK2 at 20 nM using Ulight-RRRSLLE as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	-3.0	CHEMBL4487	Homo sapiens	INH	%	-3.0
	19021599	CHEMBL4347822	Inhibition of recombinant human PAK2 at 200 nM using Ulight-RRRSLLE as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	7.0	CHEMBL4487	Homo sapiens	INH	%	7.0
	19032204	CHEMBL4349797	Inhibition of recombinant human N-terminal GST/His6-tagged PAK2 (D3 to R524) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	12.0	CHEMBL4487	Homo sapiens	INH	%	12.0
Active	19041221	CHEMBL4352482	Inhibition of human PAK2 at 10 uM using RRRLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	19059733	CHEMBL4358034	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	97.0	CHEMBL4487	Homo sapiens	Activity	%	97.0
	19090298	CHEMBL4365872	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	80.0	CHEMBL4487	Homo sapiens	Activity	%	80.0
	19092052	CHEMBL4366526	Inhibition of human PAK2 at 100 nM using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.4	CHEMBL4487	Homo sapiens	INH	%	10.4
	19159561	CHEMBL4382665	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	62.0	CHEMBL4487	Homo sapiens	Activity	%	62.0
	19191446	CHEMBL4389384	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	88.0	CHEMBL4487	Homo sapiens	INH	%	88.0
	19192047	CHEMBL4389861	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	87.0	CHEMBL4487	Homo sapiens	INH	%	87.0
	19200303	CHEMBL4391487	Binding affinity to wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	34.0	CHEMBL4487	Homo sapiens	Activity	%	34.0
	19225480	CHEMBL4395900	Inhibition of human recombinant PAK2 at 1 uM using Ulight-RRRSLLE as substrate measured after 60 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	5.58	CHEMBL4487	Homo sapiens	INH	%	5.58
	19266549	CHEMBL4405499	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	19276070	CHEMBL4408073	Inhibition of recombinant human PAK2 (3 to end residues) at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	47.0	CHEMBL4487	Homo sapiens	INH	%	47.0
	19303793	CHEMBL4414245	Inhibition of PAK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	102.0	CHEMBL4487	Homo sapiens	Activity	%	102.0
	20600612	CHEMBL4603564	Inhibition of recombinant full length human GST-tagged PAK2 expressed in baculovirus expression system using serine/threonine-20 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4487	Homo sapiens	IC50	uM	100.0
	22423371	CHEMBL4674261	Inhibition of human PAK2 using RRRLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	106.06	CHEMBL4487	Homo sapiens	Activity	%	106.06
	22423372	CHEMBL4674261	Inhibition of human PAK2 using RRRLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	99.28	CHEMBL4487	Homo sapiens	Activity	%	99.28
	22790990	CHEMBL4709495	Inhibtion of recombinant human N-terminal GST/His6-tagged PAK2 (D3 to R524 residues) expressed in sf9 insect cells assessed as residual activity at 0.1 uM using RRRLSFAEPG as substrate preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	27.98	CHEMBL4487	Homo sapiens	Activity	%	27.98
	22809803	CHEMBL4713338	Inhibition of recombinant human PAK2 (2 to end residues) assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	87.0	CHEMBL4487	Homo sapiens	Activity	%	87.0
	22818121	CHEMBL4715344	Inhibition of recombinant human N-terminal/C-terminal His6-tagged full-length PAK2 (3 to end residues) expressed in Escherichia coli at 2 uM using long S6 Kinase peptide as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL4487	Homo sapiens	INH	%	50.0
	22820534	CHEMBL4716269	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	96.0	CHEMBL4487	Homo sapiens	Activity	%	96.0
	22820535	CHEMBL4716269	Inhibition of human PAK2 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	11.0	CHEMBL4487	Homo sapiens	Activity	%	11.0
	22843629	CHEMBL4720615	Inhibition of human PAK2 using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.17	CHEMBL4487	Homo sapiens	IC50	10^-9M	1.17
	22843974	CHEMBL4720960	Inhibition of human PAK2 assessed as residual activity using RRRLSFAEPG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	100.35	CHEMBL4487	Homo sapiens	Activity	%	100.35
	22844809	CHEMBL4721484	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.33	CHEMBL4487	Homo sapiens	Activity	%	95.33
Not Active	22889539	CHEMBL4729058	Inhibition of wild-type human partial length PAK2 (P151 to R525 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
Not Active	22936052	CHEMBL4739749	Inhibition of human PAK2 at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL4487	Homo sapiens	INH		
	22952936	CHEMBL4766873	Inhibition of recombinant human PAK2 (3 to end residues) assessed as residual activity at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	74.0	CHEMBL4487	Homo sapiens	Activity	%	74.0
	22960352	CHEMBL4768660	Inhibition of PAK2 (unknown origin) using lipid substrate measured after 40 mins by ADP-glo kinase assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)NC1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL4780410	=	IC50	nM	1038.0	CHEMBL4487	Homo sapiens	IC50	uM	1.038
	22960353	CHEMBL4768660	Inhibition of PAK2 (unknown origin) using lipid substrate measured after 40 mins by ADP-glo kinase assay	B	CCn1c(=O)c(-c2ccc(-c3cncs3)cc2Cl)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21		CHEMBL3609327	=	IC50	nM	19.0	CHEMBL4487	Homo sapiens	IC50	uM	0.019
	23122366	CHEMBL4804749	Inhibition of PAK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	20200.0	CHEMBL4487	Homo sapiens	IC50	uM	20.2
	23122367	CHEMBL4804749	Inhibition of PAK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-14000.0	CHEMBL4487	Homo sapiens	IC50	uM	-14.0
	23122368	CHEMBL4804749	Inhibition of PAK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	1700.0	CHEMBL4487	Homo sapiens	IC50	uM	1.7
	23122369	CHEMBL4804750	Inhibition of PAK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	23122370	CHEMBL4804750	Inhibition of PAK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	23122371	CHEMBL4804750	Inhibition of PAK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4487	Homo sapiens	INH	%	0.0
	23122718	CHEMBL4805069	Inhibition of human PAK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	84.0	CHEMBL4487	Homo sapiens	Activity	%	84.0
	23123413	CHEMBL4805657	Inhibition of human PAK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	63.0	CHEMBL4487	Homo sapiens	Activity	%	63.0
	23123870	CHEMBL4806114	Inhibition of DNA-tagged human PAK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	74.0	CHEMBL4487	Homo sapiens	Activity	%	74.0
	23124916	CHEMBL4806674	Inhibition of human PAK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL4487	Homo sapiens	Activity	%	91.0
	23124917	CHEMBL4806674	Inhibition of human PAK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL4487	Homo sapiens	Activity	%	94.0
	23128404	CHEMBL4807943	Inhibition of PAK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4487	Homo sapiens	Activity	%	75.0
	23128405	CHEMBL4807943	Inhibition of PAK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4487	Homo sapiens	Activity	%	75.0
	23128406	CHEMBL4807943	Inhibition of PAK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4487	Homo sapiens	Activity	%	75.0
Not Active	23317554	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	82.0	CHEMBL4487	Homo sapiens	% Control	%	82.0
Not Active	23318022	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	79.0	CHEMBL4487	Homo sapiens	% Control	%	79.0
Not Active	23318688	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	93.0	CHEMBL4487	Homo sapiens	% Control	%	93.0
Not Active	23319172	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL4487	Homo sapiens	% Control	%	96.0
Not Active	23319809	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23320284	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	83.5	CHEMBL4487	Homo sapiens	% Control	%	83.5
Not Active	23320962	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23321430	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23322060	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	94.0	CHEMBL4487	Homo sapiens	% Control	%	94.0
Not Active	23322528	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23323217	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23323685	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23324081	CHEMBL4880700	PAK2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-14.0	CHEMBL4487	Homo sapiens	% inhibition	%	-14.0
Not Active	23324539	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23325174	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	69.0	CHEMBL4487	Homo sapiens	% Control	%	69.0
Not Active	23325642	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	82.0	CHEMBL4487	Homo sapiens	% Control	%	82.0
Not Active	23326289	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL4487	Homo sapiens	% Control	%	91.0
Not Active	23326757	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23327457	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23327925	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	84.0	CHEMBL4487	Homo sapiens	% Control	%	84.0
Not Active	23328512	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL4487	Homo sapiens	% Control	%	88.0
Not Active	23328980	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	85.0	CHEMBL4487	Homo sapiens	% Control	%	85.0
Not Active	23329457	CHEMBL4881164	PAK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	108.0	CHEMBL4487	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23329926	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23330394	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	64.0	CHEMBL4487	Homo sapiens	% Control	%	64.0
Not Active	23331150	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	90.0	CHEMBL4487	Homo sapiens	% Control	%	90.0
Not Active	23331618	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	87.0	CHEMBL4487	Homo sapiens	% Control	%	87.0
Not Active	23332205	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.8	CHEMBL4487	Homo sapiens	% Control	%	89.8
Not Active	23332671	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23333389	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	98.2	CHEMBL4487	Homo sapiens	% Control	%	98.2
Not Active	23334028	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	88.0	CHEMBL4487	Homo sapiens	% Control	%	88.0
Not Active	23334496	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	97.0	CHEMBL4487	Homo sapiens	% Control	%	97.0
Not Active	23334925	CHEMBL4881548	PAK2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	2.0	CHEMBL4487	Homo sapiens	% inhibition	%	2.0
Not Active	23335475	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL4487	Homo sapiens	% Control	%	99.0
Not Active	23335943	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23336570	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23337038	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23337704	CHEMBL4882075	PAK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	100.5	CHEMBL4487	Homo sapiens	% Ctrl	%	100.5
Not Active	23338119	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL4487	Homo sapiens	% Control	%	90.0
Not Active	23338587	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23339199	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	86.0	CHEMBL4487	Homo sapiens	% Control	%	86.0
Not Active	23339667	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	94.0	CHEMBL4487	Homo sapiens	% Control	%	94.0
Not Active	23340304	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23340772	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	71.0	CHEMBL4487	Homo sapiens	% Control	%	71.0
Not Active	23341429	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23341897	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	95.0	CHEMBL4487	Homo sapiens	% Control	%	95.0
Not Active	23342513	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23342981	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	86.0	CHEMBL4487	Homo sapiens	% Control	%	86.0
Not Active	23343611	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Slightly Active	23344079	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	23.0	CHEMBL4487	Homo sapiens	% Control	%	23.0
Not Active	23344717	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	84.0	CHEMBL4487	Homo sapiens	% Control	%	84.0
Not Active	23345290	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	91.0	CHEMBL4487	Homo sapiens	% Control	%	91.0
Not Active	23345758	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	79.0	CHEMBL4487	Homo sapiens	% Control	%	79.0
Not Active	23346335	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23346803	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	89.5	CHEMBL4487	Homo sapiens	% Control	%	89.5
Not Active	23347405	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	86.3	CHEMBL4487	Homo sapiens	% Control	%	86.3
Not Active	23347895	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	94.3	CHEMBL4487	Homo sapiens	% Control	%	94.3
Not Active	23348474	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23348942	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23349529	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23350147	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	91.0	CHEMBL4487	Homo sapiens	% Control	%	91.0
Not Active	23350615	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23351220	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23351688	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23352157	CHEMBL4882846	PAK2 (PAK65) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.732	CHEMBL4487	Homo sapiens	% Inhibition	%	8.732
Not Active	23352712	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	95.0	CHEMBL4487	Homo sapiens	% Control	%	95.0
Not Active	23353180	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	90.0	CHEMBL4487	Homo sapiens	% Control	%	90.0
Not Active	23354062	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23354530	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23355262	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23355730	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23356366	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23356834	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23357443	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23358090	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	83.0	CHEMBL4487	Homo sapiens	% Control	%	83.0
Not Active	23358558	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	95.0	CHEMBL4487	Homo sapiens	% Control	%	95.0
Not Active	23359144	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23359742	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23360210	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL4487	Homo sapiens	% Control	%	96.0
Not Active	23360795	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23361263	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	78.0	CHEMBL4487	Homo sapiens	% Control	%	78.0
Not Active	23361836	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23362372	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	75.0	CHEMBL4487	Homo sapiens	% Control	%	75.0
Not Active	23362840	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	60.0	CHEMBL4487	Homo sapiens	% Control	%	60.0
Not Active	23364482	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	68.0	CHEMBL4487	Homo sapiens	% Control	%	68.0
Not Active	23364950	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23365689	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	93.0	CHEMBL4487	Homo sapiens	% Control	%	93.0
Not Active	23366232	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23366822	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	66.0	CHEMBL4487	Homo sapiens	% Control	%	66.0
Not Active	23367290	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23367682	CHEMBL4884035	PAK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	83.0	CHEMBL4487	Homo sapiens	% Residual activity with Skepinone-L	%	83.0
Not Active	23368168	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	59.0	CHEMBL4487	Homo sapiens	% Control	%	59.0
Not Active	23368636	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	52.0	CHEMBL4487	Homo sapiens	% Control	%	52.0
Not Active	23369235	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	68.0	CHEMBL4487	Homo sapiens	% Control	%	68.0
Not Active	23369703	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23370175	CHEMBL4884417	PAK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	105.0	CHEMBL4487	Homo sapiens	% residual kinase activity	%	105.0
Not Active	23370671	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	75.0	CHEMBL4487	Homo sapiens	% Control	%	75.0
Not Active	23371139	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23371948	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	93.0	CHEMBL4487	Homo sapiens	% Control	%	93.0
Not Active	23372416	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23375843	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL4487	Homo sapiens	% Control	%	96.0
Not Active	23376311	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	79.0	CHEMBL4487	Homo sapiens	% Control	%	79.0
Not Active	23376888	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23377356	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23378216	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL4487	Homo sapiens	% Control	%	85.0
Not Active	23378684	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	94.0	CHEMBL4487	Homo sapiens	% Control	%	94.0
Not Active	23379851	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	77.0	CHEMBL4487	Homo sapiens	% Control	%	77.0
Not Active	23380319	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4487	Homo sapiens	% Control	%	100.0
Not Active	23381013	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	83.0	CHEMBL4487	Homo sapiens	% Control	%	83.0
Not Active	23381661	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL4487	Homo sapiens	% Control	%	92.0
Not Active	23382129	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	64.0	CHEMBL4487	Homo sapiens	% Control	%	64.0
Not Active	23382753	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	72.0	CHEMBL4487	Homo sapiens	% Control	%	72.0
Not Active	23383221	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	83.0	CHEMBL4487	Homo sapiens	% Control	%	83.0
Not Active	23383911	CHEMBL4887526	PAK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL4487	Homo sapiens	% Ctrl	%	95.0
Not Active	23384389	CHEMBL4887984	PAK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	24.95	CHEMBL4487	Homo sapiens	% inhibition	%	24.95
Not Active	23385136	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	76.0	CHEMBL4487	Homo sapiens	% Control	%	76.0
Not Active	23385603	CHEMBL4879860	KinomeScan assay: inhibition of PAK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	81.0	CHEMBL4487	Homo sapiens	% Control	%	81.0
